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 ABSTRACT 
 
The prevalence of malaria in Yemen is widespread. The aim is to study the 
clinical pattern of malaria and risk factors in children in Hajjah Province, to 
document the response to treatment and the final outcome of admitted 
children and determination of haptoglobin phenotypes among children with 
severe malaria. It is a descriptive hospital – based study involving 563 
children, birth -12 years old attending the casualty department of the 
hospital. All the children diagnosed as malaria infection were randomly 
selected in a cross sectional survey were included in the study. The age 
groups were (< 4 years),(5-8) and (9 - 12years). One hundred children 
attending the hospital for causes other than malaria matched for age and sex 
were included as the control group. Five hundred and sixty three children 
with malaria were studied. All were Yemeni, (90%) of whom were living in 
low lands of Tihama. The mean age was 4.37 ± 3.22 years, 327 (58.1%) 
were of (<4) age group, and 342 males (60.7%).The average parasitemia was 
4.78 ± 5.1, three hundred and fifty four (62.9%) had parasitemia <5%, 169 
(29.8%) had 5%-10%parasitemia and 41 (7.3%) had >10% parasitemia. 
Haptoglobin phenotype 1-1 represented (48.1%) of the cases. Haptoglobin 
type 2-1 and 2-2 represented (21.7%) and (17.6%) of the studied children 
respectively. 
Hypohaptoglobinaemia represented (12.6%) of the studied children. The 
history of fever was universal (98.9%), it was of high-grade in (99.8%) of 
the children. On examination (62.3%) had high fever, (61.8%) had severe 
anemia and (33%) had splenomegaly, (35%) had group O+ and (33.9%) had 
group A+. Renal complications were the most common (69.3%), followed 
by (17.8%) hypoglycemia,(16.2%) thrombocytopenia, (9.1%) cerebral 
malaria. The death rate was (1.6%). The mean values of all blood picture 
parameters, expect ESR, were significantly higher among children with 
cerebral malaria. The mean parasitemia level was significantly higher among 
children with cerebral malaria.There was no statistically significant 
difference between cerebral and non-cerebral malaria regarding malaria 
species and haptoglobin phenotype. It is concluded that malaria infection is 
hypoendemic in Hajjah Province, chloroquine resistance coexisted and the 
standard dose of quinine infusion (10 mg/kg/8 hourly) was found to be 
effective in severe and complicated malaria. Health education and services 
should be more developed encouraged. 
 
 
 ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
 
 
ﺇﻥ  ﺃﻫﺩﺍﻑ ﺍﻟﺒﺤـﺙ ﻫـﻲ . ﻤﻨﺘﺸﺭ ﺒﺼﻭﺭﺓ ﻭﺍﺴﻌﺔ ﻓﻲ ﺍﻟﻴﻤﻥ ( ﺍﻟﻤﻼﺭﻴﺎ)ﺇﻥ ﻤﺭﺽ ﺍﻟﺒﺭﺩﺍﺀ 
ﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻟﺘﻲ ﺘﺅﺩﻱ ﺇﻟﻰ ﺸﺩﺓ ﺍﻟﻤﺭﺽ ﻭﺍﻟﻭﻓﻴﺎﺕ ﺍﻟﻨﺎﺘﺠﺔ  ﺍﻟﻤﺨﺘﻠﻔﺔ ﻟﻠﻤﺭﺽ ﻭﺘﺤﺩﻴﺩ ﺩﺭﺍﺴﺔ ﺍﻟﺼﻭﺭ 
ﻋﻨﻬﺎ ﻭﺩﺭﺍﺴﺔ ﻋﻭﺍﻗﺏ ﺍﻟﻤﺭﺽ ﻭﺘﺄﺜﻴﺭ ﺍﻟﻌﻼﺝ ﻭﺘﺤﺩﻴﺩ ﻨﻭﻉ ﺍﻟﻬـﺎﺒﺘﻭﺠﻠﻭﺒﻴﻥ ﺒـﻴﻥ ﻫـﺅﻻﺀ ﺍﻷﻁﻔـﺎل 
 ﻁﻔﻼ ﻤﺼﺎﺏ ﺒﺩﺍﺀ ﺍﻟﻤﻼﺭﻴﺎ ﻤـﻥ ﺍﻟـﺫﻴﻥ 365ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻭﺼﻔﻴﺔ ﻤﻴﺩﺍﻨﻴﺔ ، ﺘﻡ ﺍﺨﺘﻴﺎﺭ  .ﺍﻟﻤﺼﺎﺒﻴﻥ 
ﺘﺭﺍﻭﺤﺕ ﺃﻋﻤﺎﺭﻫﻡ . ﺘﺸﻔﻰ ﺍﻷﻁﻔﺎل ﺍﻟﺴﻌﻭﺩﻱ  ﺍﻟﻤﻘﺎﻡ ﻭﺴﻁ ﻤﺩﻴﻨﺔ ﺤﺠﺔ ﺒﺎﻟﻴﻤﻥ ﻤﺴ ﺃﺩﺨﻠﻭﺍ ﻁﻭﺍﺭﺉ  
، (  ﺴـﻨﻭﺍﺕ 4ﺍﻗل ﻤﻥ )ﺘﻡ ﺘﻘﺴﻴﻡ ﻤﺠﻤﻭﻋﺔ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺜﻼﺙ ﻤﺠﻤﻭﻋﺎﺕ .  ﺴﻨﺔ 21  ﺇﻟﻰ ﺓﻭﻻﺩﺍﻟﻤﻥ 
، ﻜﻤﺎ ﺘﻡ ﺍﺨﺘﻴﺎﺭ ﻤﺎﺌﺔ ﻁﻔل ﻤﻥ ﻨﻔﺱ ﺍﻷﻋﻤـﺎﺭ ﻭﺍﻟﺠـﻨﺱ ﻜﻌﻴﻨـﺔ (  ﺴﻨﺔ 21-9) ﻭ (  ﺴﻨﻭﺍﺕ 8-5)
  . ﻤﻘﺎﺭﻨﺔ 
 ( ﻤﻨﻁﻘﺔ ﺍﻟﺴﻬل ﺍﻟـﺴﺎﺤﻠﻲ )ﻤﻥ ﻤﻨﻁﻘﺔ ﺘﻬﺎﻤﺔ  % 09ﺠﻤﻴﻊ ﺍﻟﻤﺭﻀﻰ ﻴﻤﻨﻴﻭﻥ ، ﺃﻭﻀﺤﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ 
 4 - ﺍﻟـﻭﻻﺩﺓ  ﻜﺎﻨﻭﺍ ﻤـﻥ (%85) 723 ﺴﻨﺔ ، ﻏﺎﻟﺒﻴﺔ ﺍﻷﻁﻔﺎل  22.3 ± 73.4،ﻭﻤﺘﻭﺴﻁ ﺍﻷﻋﻤﺎﺭ 
ﺒﻴﻨﻤﺎ % 5.98ﻴﻤﺜل ( ﻓﺎﻟﺴﻴﺒﺎﺭﻡ) ﻭﺠﺩ ﺃﻥ ﻁﻔﻴل ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﻤﻨﺠﻠﻴﺔ . ﺫﻜﻭﺭ%( 7.06)243ﺴﻨﺔ، ﻭﺃﻥ 
ﻜﻤﺎ ﻭﺠـﺩ ﺃﻥ ﻤﺘﻭﺴـﻁ . ﻤﻥ ﻤﺠﻤﻭﻉ ﺍﻟﺤﺎﻻﺕ % 7.0ﻥ ﻤﻌﺎ ً ﻴﻤﺜﻼﻥ ، ﻭﺍﺜﻨﻴ %8.9ﻴﻤﺜل ( ﻓﻴﻔﺎﻜﺱ)
% 5ﻤﻥ  ﺤﺎﻟﺔ ﻭﺠﺩ ﺃﻥ ﻨﺴﺒﺔ ﺍﻟﻁﻔﻴل ﺒﺎﻟﺩﻡ ﺃﻗل %( 9.26 )453 ﻭﻓﻲ 1.5 ±% 87.4ﺍﻟﻁﻔﻴل ﺒﺎﻟﺩﻡ 
ﻜﺎﻨﺕ ﻨﺴﺒﺔ ﺍﻟﻁﻔﻴل ﺒﺎﻟـﺩﻡ %( 3.7 )14ﻭﻓﻲ % 01 -% 5ﺤﺎﻟﺔ ﺘﺘﺭﺍﻭﺡ ﺒﻴﻥ %( 8.92 )961ﻭﻓﻲ 
% 7.12 ﻨـﺴﺒﺔ 1-2ﻤﻥ ﺍﻟﺤـﺎﻻﺕ، % 1.84  ﻤﻥ ﺍﻟﻬﺎﺒﺘﻭﺠﻠﻭﺒﻴﻥ ﻨﺴﺒﺔ 1-1ﻤﺜل %.01ﺃﻜﺜﺭ ﻤﻥ 
ﻤﻥ ﺍﻟﺤﺎﻻﺕ ﻴﻭﺠﺩ ﻟـﺩﻴﻬﻡ ﻫـﺎﺒﺘﻭﺠﻠﻭﺒﻴﻥ % 6.21ﻤﻥ ﺍﻟﺤﺎﻻﺕ، ﺒﻴﻨﻤﺎ %  6.71 ﻤﺜل 2-2ﻭﻨﻭﻉ  
ﺍﺸﺘﻜﻭﺍ ﻤﻥ ﺍﻟﺤﻤﻰ، ﻭﻜﺎﻨﺕ ﺩﺭﺠـﺔ ﺍﻟﺤـﺭﺍﺭﺓ ﻤﺭﺘﻔﻌـﺔ ﻓـﻲ %( 9.89) ﻜل ﺍﻟﺤﺎﻻﺕ . ﺒﻜﻤﻴﺔ ﻗﻠﻴﻠﺔ 
  . ﻤﻥ ﻫﺫﻩ ﺍﻟﺤﺎﻻﺕ%( 8.99)
 % 33ﻟﺩﻴﻬﻡ ﻓﻘـﺭ ﺩﻡ ﺸـﺩﻴﺩ، % 8.16ﻰ ﻤﺭﺘﻔﻌﺔ، ﻟﺩﻴﻬﻡ ﺤﻤ % 3.26ﺒﺎﻟﻔﺤﺹ ﺍﻹﻜﻠﻴﻨﻴﻜﻲ ﻭﺠﺩ ﺃﻥ 
               ﻤـﻥ ﺍﻟﺤـﺎﻻﺕ ﻓـﺼﻴﻠﺔ ﺩﻤﻬـﻡ % 53ﺒﺎﻟﻨـﺴﺒﺔ ﻟﻔـﺼﺎﺌل ﺍﻟـﺩﻡ ﻓـﺈﻥ . ﻟﺩﻴﻬﻡ ﺘﻀﺨﻡ ﻓﻲ ﺍﻟﻁﺤﺎل 
ﻤﻥ ﺍﻟﺤﺎﻻﺕ ﻟﺩﻴﻬﻡ ﻤﻀﺎﻋﻔﺎﺕ ﻓـﻲ ﺍﻟﻜﻠـﻰ، % 3.96ﻭﺠﺩ . ()+A ﻤﻥ ﺍﻟﺤﺎﻻﺕ% 9.33،  )+ O(
ﻤـﻥ % 6.1 ﻜﺎﻨـﺕ ﺍﻟﻭﻓﻴﺎﺕﺔ ﻤﻼﺭﻴﺎ ﺩﻤﺎﻏﻴﺔ، ﻜﻤﺎ ﻭﺠﺩ ﺃﻥ ﻨﺴﺒ % 1.9ﻨﻘﺹ ﻓﻲ ﺍﻟﺴﻜﺭ، % 8.71
ﻭﺠﺩ ﺃﻥ ﻨﺘﺎﺌﺞ ﻤﺘﻭﺴـﻁ ( ﻤﺎ ﻋﺩﺍ ﺴﺭﻋﺔ ﺍﻟﺘﺭﺴﻴﺏ )ﻟﻔﺤﻭﺼﺎﺕ ﺍﻟﺩﻡ ﻋﺎﻤﺔ  ﺒﺎﻟﻨﺴﺒﺔ .ﻤﺠﻤﻭﻉ ﺍﻟﺤﺎﻻﺕ 
ﻜﻤﺎ ﻭﺠﺩ ﺃﻥ ﻤﺘﻭﺴﻁ . ﺃﻜﺜﺭ ﻓﻲ ﺍﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ ﻭﺫﺍﺕ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ  ﻜﺎﻨﺕ ﺍﻟﻘﻴﻡ ﻟﻬﺫﻩ ﺍﻟﻔﺤﻭﺼﺎﺕ 
ﻟﻡ ﻴﻜـﻥ . ﺎﻥ ﺫﺍ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ ﺍﻷﻁﻔﺎل ﺍﻟﻤﺼﺎﺒﻴﻥ ﺒﺎﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ ﻭﻜ  ﺒﻴﻥ ﺍﻟﻁﻔﻴل ﻓﻲ ﺍﻟﺩﻡ ﺃﻋﻠﻰ 
ﻫﻨﺎﻙ ﻓﺭﻕ ﺫﻭ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ ﺒﻴﻥ ﺍﻟﻤﺼﺎﺒﻴﻥ ﺒﺎﻟﻤﻼﺭﻴﺎ ﺍﻟﺩﻤﺎﻏﻴﺔ ﻭﺍﻷﻁﻔﺎل ﺍﻟﻐﻴﺭ ﻤﺼﺎﺒﻴﻥ ﺒﻬﺎﺒﺎﻟﻨﺴﺒﺔ 
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1. INTRODUCTION AND LITERATURE REVIEW 
 
1.1. INTRODUCTION: 
Malaria remains a major problem through out most of the tropical 
and subtropical areas. Malaria is mostly caused by Plasmodium falciparum  
and is major cause of morbidity and mortality in tropical Af!rica. The 
infection ranges from asymptomatic infections, through mild and severe 
febrile illness to acute fulminating infections, which are rapidly fatal (1).   
According to WHO reports, malaria risk of varying degrees exists 
in 100 countries. In 92 of them, transmission is of the malignant form 
(Plasmodium falciparum). As reported in 1996 the global malaria situation is 
serious and becoming worse with the increasing incidence of malaria in the 
world at a rate of 300 to 500 million clinical cases annually. About 0.5 to 2.7 
million people die of malaria every year, mainly among African children 
under the age of 5 years(2) .  
The disease is sometimes associated with severe complications 
mainly cerebral malaria, hyperpyrexia, renal failure, pulmonary edema and 
anemia. These occurred mainly among children in areas of low and 
moderate transmission.  
 
1.2. LITERATURE REVIEW 
 
1.2.1. Historical background: 
Malaria has been known for thousands of years; recognizable 
descriptions of the disease were recorded in various Egyptian papyri. The 
Ebers papyrus (3550 B.P.) mentioned fevers, splenomegaly, and the use of 
oil of the balamites tree as a mosquito repellent. Hieroglyphs on the walls of 
the ancient Temple of Denderah in Egypt described an intermittent fever 
following the flooding of the Nile (3).  
Hippocrates studied medicine in Egypt and clearly described 
quotidian, tertian, and quatrain fevers with splenomegaly. He believed that 
bile was the cause of the fever. Greek states built beautiful cities in the 
lowlands only to see them devastated by the disease. Herodotus (2500-2424 
B.C.) stated that Egyptian fishermen slept with their nets arranged around 
their beds so that mosquitoes could not reach them (4). 
In parts of Asia, the documented history of malaria goes back  to 
more than 2000 years (5). 
1.2.2. Definition of Malaria: 
Malaria is a disease characterized by recurrent fever and chills 
associated with the synchronous lysis of parasitized red blood cells. Its name 
is derived from the belief of the ancient Romans that malaria was caused by 
the bad air of the marshes surrounding Rome (6).  
Malaria is one of the most serious parasitic diseases caused by 
protozoal parasites of the genus plasmodium, which has four species that 
infect human. Plasmodium falciparum, Plasmodium ovale, Plasmodium 
vivax and Plasmodium malariae. Plasmodium falciparum is the commonest 
species in most of the endemic areas and causes the most serious form of the 
disease and it sometimes associated with serious complications such as 
cerebral malaria, acute renal failure, hepatic failure, pulmonary edema and 
black water fever (1).  
1.2.3. Global Incidence of Malaria and Magnitude of the Problem: 
Malaria is an infectious disease caused by the parasite called 
plasmodium. It is re-emerging as the first infectious Killers and it is the 
Number one Priority Tropical Disease of the World Health Organization. 
Malaria affects more than 2400 million people i.e. More than 40% of 
the world's population at risk of exposure in more than 100 countries in the 
tropics from South America to the Indian peninsula. The tropics provide 
ideal breeding and living conditions for the anopheles mosquito, and hence 
this distribution.  
Malaria ranks third among the major infectious diseases in causing 
deaths-after pneumococcal acute respiratory infections and tuberculosis.  
The period from the 1950s to the 1990s has witnessed near 
"eradication" followed by resurgences of malaria in Sri Lanka. The effect of 
war and postwar instability on drug resistance in Cambodia, increase in 
severe and cerebral malaria in Myanmar during prolonged political turmoil, 
the essential disappearance of the disease form all but forested border areas 
of Thailand where it remains for the moment intractable, the basic 
elimination of vivax  malaria form many provinces of central China(5) . 
Countries of the Eastern Mediterranean Region are situated in three 
eco-epidemiological zones of malaria: Afrotropical, oriental and palaearctic. 
Consequently, there are striking dissimilarities between the countries of the 
region in relation to the malaria problem, although all of them are malaria – 
receptive(7). About 45% of the population of the Eastern Mediterranean 
Region lives under the risk of both falciparum and vivax malaria, and 
additional 15% under the risk of P. vivax alone. The estimated annual 
number of malaria cases is about 14 millions, out of which 95% occur in 
four countries: Afghanistan, Somalia, Sudan and Yemen (8).   
Malariogenic conditions are most favorable in the areas of 
Afrotropical that encompass sub-Saharan Africa, (including Djibouti, 
Somalia and Sudan), Yemen, (with exception of Sokatra island) and the 
adjoining south-western part of Saudi Arabia (9) .  
The main feature of Afrotropical malaria is the predominance of P. 
falciparum, which is highly endemic and refractory to control measures, this 
is mostly due to the presence of vectors belonging to the An. Gambiae 
complex, primarily An. Gambiae S.S and An. Arabiensis(10) with favorable 
humidity, temperature and breeding sites. 
In North Africa that belongs to a palaearctic region many areas were 
highly endemic and heavily affected by P. falciparum, but transmission was 
always comparatively low, seasonal and maintained by relatively weak 
vectors. 
The oriental type of malaria is characterized by the presence of both 
P. falciparum and P.vivax in roughly equal proportions and the involvement 
of rather effective vectors, primarily those belonging to the complexes of 
An.culicifacies, An.fluvialis and An.stephensi. Oriental malaria is more 
difficult to control compared to paratactic malaria(11, 12).  
The small grants scheme for tropical disease ( SGS ) research and 
epidemiological Situation of malaria in the countries of the Eastern 
Mediterranean Region (EMR) form a broad spectrum of malaria situations 
showed dissimilarities between the countries of the region. Children under 
the age of five years and pregnant women are particularly vulnerable. The 
estimated annual number of malaria cases is about 15 million, out of which 
95% are believed to occur in four countries (group4). Malaria situation in 
the Region underwent a complicated evolution. On considering the 
epidemiological categories of malaria, EMR notified the burden of the 
disease within each category rather than within each individual country of 
the Region. The epidemiological category in SGS research is divided in 4 
groups (5). 
% Contribution in SGS Epidemiological category 
Individual EMR countries Total (By Group) 
Group 1: Counties that achieved 
interruption of malaria 
transmission (Malaria free)  
Bahrayn, Cyprus Jordan, 
Libya, Palestine (0%) 
Lebanon (3%) 
Tunisia (7%) 
10% 
Group 2: Countries where 
malaria is firmly under control 
and are targeting the 
eradication: 
UAE (0%) 
Syria  (0%) 
Morocco (0%)  
Oman (3%), Egypt (17%) 
 20% 
Group 3: Countries with a 
moderate endemicity and 
relatively well established 
control programmers:  
Iraq (0%) 
Saudi Arabia (7%) 
Iran (10%) 
Pakistan (13%) 
30% 
Group 4: Countries with a 
severe malaria problem and/or 
threatened by epidemics and 
complex situations : 
Afghanistan 0% 
Djibouti 0% 
Somalia 3% 
Yemen (7%), Sudan (30%) 
40 % 
In countries of severe malaria (group 4), Sudan contains more than 
half of the total estimated malaria cases in the Region. It has more than 8 
million cases and about 35000 deaths per year(2, 13).  
Sudan recorded the highest frequency of implemented projects 
(29%) which is in agreement with its epidemiological situation regarding 
malaria control (group 4) as a country with a severe malaria problem and/or 
threatened by epidemics and complex situations (14), on the other hand, in 
countries with epidemiological situation comparable to Sudan either no 
research has been conducted (Afghanistan and Djibouti), or rarely 
performed (Yemen 7%, Somalia 3%). 
In the Republic of Yemen, malaria is a top priority health problem, 
and 60% of the population is estimated to be at risk of malaria(15), 20% of 
the estimated cases in the EMR (Eastern Mediterranean Region) occur in 
this country. 
In Afghanistan more than 50% of the population lives in malaria 
endemic areas, producing more than 10% of the estimated cases in the 
Region.  
1.2.4. Routes of Transmission: 
Malaria is typically transmitted by the bite of an infective female 
anopheles mosquito. Mosquito-born cases are referred to as autochthonous 
malaria to distinguish them from cases transmitted in other ways. 
Congenital malaria refers to infection passed from mother to infant in utero. 
Induced malaria refers to infection that is passed directly from one 
individual to another through contaminated blood or blood products, 
injection equipment, or organ transplant. Until late in the 1950s, induced 
malaria infection was widely practiced as a treatment for late 
neurosyphilis(16). While this treatment has been replaced by effective 
antibiotics, the practice of malariotherapy has reemerged several times in 
recent decades in economically developed countries(17). When a route of 
transmission cannot be established, a case may be classified as cryptic 
malaria (18).  
1.2.5. Life Cycle of malaria parasite: 
    The life cycle of all human species consists of two phases, sexual 
phase ( sporogony ) in anopheles mosquito, and an asexual phase 
(schizogony ) in humans(4).   
1.2.5.1. The parasite in the vertebrate host ( asexual phase ): 
• Tissue phase (Exo –Erythrocytic schizogony) : 
    The sporozoites in the saliva of the infected anopheles  mosquitoe, 
are injected into man during feeding. Within half an hour, they enter the 
liver cells, where, they undergo development and multiplication into 
exoerythrocytic schizonts. The sporozoite is about 10-15 µm long by 1 µm 
in diameter(19). In P.vivax and P.ovale malaria, some of the exoerythrocytic 
schizonts remains dormant, for a period of months. These are known as the 
hypnozoites(20). A protein covering the surface of  the sporozoite 
(circumsporozoite protein ) binds to receptors on the basolateral domain of 
the hepatocyte cell membrane(21). The hypnozoites become active and 
mature into merozoites, which infect red cells and give rise to an 
erythrocytic phase. This is the mechanism responsible for relapses in vivax 
and ovale malaria. While Plasmodium falciparum and plasmodium malariae 
do not form hypnozoites, infection with these parasitescan persist in the 
blood at undetectable levels following resolution of symptoms. Except in 
partially immune persons, plasmodium falciparum rarely recrudesces more 
than several months after initial infection(22).  
• Erythrocytic schizogony phase: 
When the tissue schizonts rupture, they release many thousands of 
merozoites, which enter the circulation. In the red cells the merozoites 
develop into ring forms. It grows in size to trophozoites, which multiply by 
schizogony, divided into a number of small merozoites, varying with the 
species, to form mature schizonts(23). The hemozoin and merozoites are 
released by rupture of the red cell membrane. The merozoites then invade 
new red cells to initiate a new sequence of intracellular parasitic growth and 
schizogony. Hemozoin has a toxic effect on macrophages, depressing their 
effectiveness as phagocytes(24). After  a period, some merozoites give rise to 
two sexually differentiated forms of gametocytes. A male 
(microgametocyte), and a female (macrogametocyte), which differ in 
morphology in the different species of parasites(25). These gametocyte are 
taken up by female anopholine mosquitoe, where they undergo further 
development 
1.2.5.2. Classification of Plasmodium malaria parasites: 
There are four species of Plasmodium normally parasitic in humans: 
P. falciparum, P. vivax, P. malariae, and P. ovale (26). Ultrastructural 
evidence supports the relationship of P. falciparum to the avian plasmodia 
(25). 
• Plasmodium vivax: Plasmodium vivax is the cause of benign tertian 
malaria, also known as vivax malaria or tertian ague. When early Italian 
investigators noted the actively motile trophozoites of the organism within 
host corpuscles, they nicknamed it vivace, foreshadowing the Latin name 
vivax. The designation tertian is based on the fact that fever paroxysms 
typically recur every 48 hours; the name is derived from the ancient 
Roman custom of calling the day of an event the first day, 48 hours later 
hence being the third(4). Most vivax malaria today is found in Asia; about 
40% of malaria among United States military personnel in Vietnam 
resulted from P. vivax (27).  It is common in North Africa but drops off in 
tropical Africa to very low levels, partly because of a natural resistance of 
black persons to infection with this species. About 43% of malaria in the 
world is caused by P. vivax (4). 
• Plasmodium falciparum: Malaria known as malignant tertian or 
subtertian, is caused by P. falciparum, the most virulent of Plasmodium 
species in humans. Falciparum malaria is the greatest killer of humanity 
in the tropical zones of the world today, it accounts for about 50% of all 
malaria cases(4). 
• Plasmodium malariae: Quatrain malaria, with paroxysms every 72 hours, 
is caused by P. malariae. In 1885 Gilgi differentiated the tertian and 
quatrain fevers and gave an accurate description of what is known as P. 
malariae(4). It may be the only human malaria organism that also regularly 
lives in wild animals(28). This species accounts for about 7% of malaria 
cases in the world(4). 
• Plasmodium ovale: This species causes ovale or mild tertian malaria and 
is the rarest of the four malaria parasites of humans. It is confined mainly 
to the tropics, although it has been reported from Europe and the United 
States. Although common on the West Coast of Africa, which may be its 
original home, the species is scarce in Central Africa and present but not 
abundant in Eastern Africa. It is known also in India, the Philippine 
Islands, New Guinea, and Vietnam. Plasmodium ovale is difficult to 
diagnose because of its similarity to P. vivax(4). 
 
1.2.6. Pathogenesis and Clinical Manifestations: 
The pathogenesis of severe plasmodium malaria in African children 
is considered in the context of its two major clinical syndromes: Malaria 
with respiratory distress and malaria with neurological disturbance. 
Respiratory distress is an important prognostic marker in children with P. 
falciparum infections. In the majority of cases it reflects an underlying 
metabolic acidosis, usually associated with lactic acidemia. Hypovolaemia 
and anemia are important underlying factors. The syndrome of malaria with 
neurological impairment is not a homogenous condition. Four distinct 
groups of children fulfilling the WHO definition of cerebral malaria may be 
distinguished: (1) prolonged post-ictal state; (2) overt status epilepticus; 
(3)severe metabolic derangement (particularly hypoglycemia and metabolic 
acidosis); and (4) children with primary neurological syndrome (29). A simple 
framework is presented to summarize how these three major processes, 
anaemia, the acute phase response and sequestration of infected cells, may 
interact to lead to reduced tissue oxygenation as unifying important net 
result process of this interaction in the pathogenesis of both major clinical 
syndromes of severe malaria (29). 
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 Framework for the pathogenesis of severe malaria 
 
Life-threatening malaria is prescribed in terms of two distinct but 
overlapping syndromes: malaria with respiratory distress; and malaria with 
neurological disturbances (29). The presence of either of these easily defined 
syndromes on admission to hospital has greater prognostic value than that 
achieved by using the combined clinical and laboratory indices of the WHO 
definition(29). The breathless child is well recognized and is usually ascribed 
to anemia with congestive heart failure. Neither ARDS nor pulmonary 
oedema has been formally documented as features of malaria in African 
children (nor do they turn out to be the basis of the respiratory distress that 
we have documented). The term "respiratory distress" is used because, 
unlike pulmonary oedema or congestive cardiac failure, it carries no 
aetiological implications (29). 
The causes for respiratory distress in children with malaria include 
cardiac failure, co-existent pneumonia, direct sequestration of malaria 
parasites in the lung, or increased central drive to respiration in association 
with cerebral malaria. However, in the large majority of cases, respiratory 
distress is associated with a metabolic acidosis (29). 
Deep breathing is an accurate clinical indicator of the presence of 
acidosis, it is highly sensitive and specific for the summary diagnosis of 
respiratory distress (29). Lactic acidosis appears to be the major (but not the 
only) contributing mechanism of acidosis. In majority of cases (85%) 
acidosis is associated with a significant lactic acidaemia, which is considered 
to be a feature of Gambian children with severe malaria. It is the minority of 
patients, whose hyperlactataemia does not resolve in the first few hours of 
admission, that the prognosis is worse. Lactic acid could accumulate in 
malaria by any one or a combination of four potential mechanisms. Firstly 
the malarial parasite itself produces lactate. Secondly, hepatic blood flow is 
reduced in severe malaria and reduced function of the liver, a primary site of 
lactate disposal, may lead to decreased clearance of lactate. Thirdly, malaria 
is associated with a marked acute-phase response, with cytokines reaching 
high concentration. Tumor necrosis factor and other cytokines may lead to 
the production of the lactate by direct effects on cellular metabolism. 
Finally, and most importantly, the pathological production of lactate is most 
commonly the end result of reduced delivery of oxygen to the tissues(29). 
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Possible mechanisms of lactic acidosis in severe malaria 
 
Acidaemia is a manifestation of severe malaria, whether there is 
altered consciousness or not. Acidosis is the major independent risk factor 
for death, but is also strongly associated with hypoglycemia, a known risk 
factor for death in malaria (29). 
The classical histopathological picture of cerebral malaria is intense 
sequestration of infected cells in the cerebral microvasculature. The clinical 
syndrome of cerebral malaria is heterogenous and comprises syndromes 
likely to have quite different pathogenesis. 
 
 
The Syndrome of cerebral malaria consists of: 
? Seizures ? secondary coma (prolonged post-ictal state).  
? Seizures ? coma (covert status epilepticus).  
? Acidosis/ metabolic disturbance ? Secondary coma.  
? Primary brain lesion ? coma + seizures (classical cerebral malaria) 
Most of the clinical manifestations of malaria may be attributed to 
two general factors: (1) the host inflammatory response, which produces the 
characteristic chills and fever, as well as other related phenomena; and (2) 
anemia, arising from the enormous destruction of red blood cells. Severity 
depends on the species, P.falciparum is the most serious and P.vivax and 
P.ovale the least dangerous(4). 
1.2.6.1. Fever: 
The estimated parasite density threshold for initiation of a febrile 
episode was 100 parasite per µL of blood in infants, compared with 3500 
parasite per µL in children over one year of age(30). 
Fever is a common nonspecific reaction of the body to infection, 
functioning at least in part to increase the rate of metabolic reactions 
important in host defense. Fever in malaria is correlated with the maturation 
of a generation of merozoites and the rupture of the red blood cells that 
contain them. It is widely believed that fever is stimulated by the waste 
products of the parasites, released when the erythrocytes lyses. Release of 
these malarial antigens into the circulation apparently triggers a burst of 
tumor necrosis factor (TNF) from activated macrophages (31, 32). 
Induction of fever is among the effects of overproduction of TNF, 
and TNF toxicity can account for most or all of the following symptoms: 
malaise, muscle pain, headache and loss of appetite. A typical attack of 
benign tertian or quatrain malaria begins with a feeling of intense cold as the 
hypothalamus, the body’s thermostat, is activated, and the temperature then 
rises rapidly to 104؛-106؛ F. the teeth chatter, and the bed may rattle from the 
victim’s shivering. Nausea and vomiting are usual. The hot stage begins 
within one-half to one hour later. As copious perspiration signals the end of 
the hot stage, the temperature drops back to normal within 2-3 hours, and the 
entire paroxysm is over within eight to twelve hours. The person may sleep 
and feel well until the next paroxysm(31). The stages are shorter in quatrain 
malaria, and the paroxysms recur every 72 hours. In vivax malaria the 
periodicity is quotidian early in the infection, since two populations of 
merozoites usually mature on alternate days. “Double” and “Triple” quatrain 
infections are known. Only after one or more groups drop out does the fever 
become tertian or quartan, and the patient experiences the classical good and 
bad days(4).  
Because the synchrony in falciparum malaria is much less marked, 
the onset is often more gradual, and the hot stage is extended. The fever 
episodes may be continuous or fluctuating, but the patient does not feel well 
between paroxysms, as in vivax and quatrain malaria. In cases in which 
some synchrony develops, each episode lasts 20 to 36 hours, rather than 8 to 
12 hours, and is accompanied by nausea, vomiting, and delirium. Concurrent 
infections with Plasmodium vivax and Plasmodium falciparum are 
common(4). 
However, since malaria cases do not always present with measurable 
fever, and since asymptomatic parasitemia occurs, additional episode 
markers might be useful as epidemiological tools. High C-reactive protein 
levels are therefore probably indicative of recent clinical malaria episodes in 
afebrile individuals with high parasite densities(33). 
1.2.6.2. Anemia: 
Hemolysis is the prime cause of the anemia seen in acute falciparum 
malaria, although destruction of parasitized erythrocytes is not the sole cause 
of the hemolytic process(34). Severe anaemia is often multifactorial and is 
attributable to malaria because of parasitaemia and the lack of an adequate 
alternative explanation(35).   
The main causes of anemia are destruction of both parasitized and 
nonparasitized erythrocytes, inability of the body to recycle the iron bound 
in the insoluble hemozoin, and an inadequate erythropoitic response of the 
bone marrow(32). Why such large numbers of non-parasitized red cells are 
destroyed is still not understood, but some evidence has indicated 
complement-mediated, autoimmune hemolysis. For reasons yet unclear, the 
spleen in acute malaria removes substantial numbers of unparasitized red 
cells from the blood, an effect that may persist beyond the time of parasite 
clearance. Both the splenic removal of red cells and the defective bone 
marrow response may be due in part to TNF toxicity(31).  
In a study conducted in Sudan, it was found that serum Erythropoietin 
(Epo) levels in Sudanese children suffering from malaria, rarely exceeds 300 
U/L. For comparison, serum Epo was increased up to 12.000 U/L in 
Caucasian patients with anemia not associated with malaria infection. 
Treatment with the antimalarial drug chloroquine may aggravate the defect 
in Epo production(36).  
Hemoglobin concentration correlates directly with haptoglobin and 
inversely with unconjugated bilirubin in malaria patients. Parasitemia not 
significantly correlates with hemoglobin concentration(34). On the other 
hand, the degree of anemia correlates with the levels of parasitemia and 
schizontemia. It is also associated with high serum bilirubin and creatinine 
levels(37). 
Severe anemia inversely correlates with age, it declines from 73% to 
52%, then 26% among children aged < 3 years, 4-7 years and 8-15 years 
respectively(38). 
Children may have severe anemia even with low parasitemia. A 
hemoglobin level of less than 7.1g % (4.4 mmol/L) should serve as a 
warning for impending crisis, hemoglobin of less than 5g % (3.1 mmol/L) is 
an indication for transfusion of packed cells(37).  
The mean hemoglobin concentration among children having pallor is 
significantly lower than that among children not considered to have pallor. 
More children with pallor died compared with those without pallor (17.6% 
versus 7.2%). They added, the clinical observation of pallor might therefore 
identify children with low hemoglobin concentrations and a high risk of 
mortality(39).  
The low platelet count in malaria patients is due to sequestration of 
platelet in the spleen, rather than failure of production by the bone marrow 
or immune-mediated lysis(40). 
Destruction of erythrocytes leads to an increase in serum bilirubin. 
When its excretion cannot keep up with formation, jaundice occurs. The 
hemozoin is taken by circulating leukocytes. After ingesting the hemozoin, 
macrophages suffer impairment in phagocytic ability (24). 
About 30% of patients with malaria present with jaundice(40, 41). The 
cause of jaundice in patients with malaria may be explained by one or more 
factors, and these include intravascular hemolysis, hepatic dysfunction and 
micro-angiopathic hemolysis associated with disseminated intravascular 
coagulation (DIC)(42).  
1.2.6.3. Gastrointestinal manifestations: 
The gastrointestinal manifestations of acute symptomatic 
uncomplicated falciparum malaria were studied in 184 children aged from 6 
months-15 years, in University Hospital of Ibadan, Nigeria. Vomiting was 
the most common presenting symptom. Peripheral parasite density was 
higher in children who were vomiting than in those who were not. There was 
no relationship between the density of peripheral parasitemia and the 
duration of gastrointestinal symptoms at presentation. All gastrointestinal 
symptoms cleared within 3 days after instituting antimalarial therapy(43).  
Malarial diarrheas in children are variable and sometimes clinically 
indistinguishable from other diarrheas in malaria endemic areas. The 
majority of cases of diarrhea with malaria were in age group of less than one 
year(44).  
1.2.6.4. Hamoglobinuria and black water fever: 
Black-water fever has become exceptional since 1950, when quinine 
was replaced by chloroquine. The disease reappeared in 1990, following the 
re-utilization of quinine because of resistance to chloroquine. Black-water 
fever is a clinical entity characterized by acute intravascular hemolysis 
classically occurring after the re-introduction of quinine in long-term 
residents in Plasmodium falciparum endemic areas who repeatedly use the 
product. Manifestations appear with emission of porto-colored urine, icterus, 
pallor, nausea, fever and acute renal failure. Parasitemia is mild or absent. 
The mechanism of renal failure is tubular necrosis(45) . Malaria 
haemoglobinuria is uncommon and is usually associated with 
hyperparasitaemia. It may or may not be accompanied by renal failure. The 
patient is commonly anaemic(46).   
1.2.7. Classification of Malaria:    
Malaria is classified into: 
1.2.7.1. Mild (simple) malaria:   
              Febrile illness in a subject with asexual Plasmodium falciparum 
parasites in blood film, without any other satisfactory explanation for the 
fever, and without cerebral or severe malaria. 
1.2.7.2. Severe malaria:  
              Subject that showed severe malaria due to Plasmodium falciparum 
hyper- parasitaemia (> 100.000 parasite /µL) or any presence of Plasmodium 
falciparum parasitaemia and one of the following: coma, hypoglycemia 
(glucose < 2.2 mmol/L), severe anemia (haematocrite < 20%) or 
(hemoglobin <7.0 g/dl), serum creatinine > 3.0 mg/dl and serum 
transaminase level > 100 units(47) . 
Malaria infection is considered severe in the presence of high level 
of parasitaemia (> 4/high-power field of erythrocytes parasitised by 
Plasmodium falciparum), or the presence of parasitaemia and the association 
of severe manifestations and complications(41). These complications include: 
coma, convulsions, shock or severe anemia (hematocrite <20% or 
hemoglobin <50 gm/L), intravascular hemolysis (hemoglobinuria), 
hypoglycemia (glucose <2.2 mmol/L), renal impairment (serum creatinine 
>265 µmmol/L), coagullopathy, acute respiratory distress syndrome and 
acidosis.    
In young children, features of severe malaria include severe anemia, 
hypoglycemia and cerebral malaria(48).  
Severe malaria is uncommon compared to mild or asymptomatic 
malaria infection(49). 
In areas of endemic malaria, the most common clinical presentation 
is that of uncomplicated infection with prompt recovery after treatment(2, 50). 
However, in non-immune individuals, malaria may present in its most severe 
forms(51).  
No significant influence of socioeconomic factors could be detected 
on the severity of disease or the time to first reinfection. Socioeconomic 
factors are not major determinants of severe malaria anemia and 
hyperparasitemia in children(52).  
1.2.8. Complications of malaria: 
Falciparum malaria produces severe complications. The most 
common is cerebral malaria(2). Another grave and fatal complication of 
severe falciparum malaria is pulmonary edema, which in some cases may be 
a result of over administration of intravenous fluids(32).   
Other acute complications include renal failure, hemolytic anemia, 
hypoglycemia, metabolic acidosis, disseminated intravascular coagulation, 
and shock(53).  
A combination of other severe manifestations is known as algid 
malaria, which is a rapid development of shock. There is circulatory 
collapse with markedly low blood pressure and the skin is cold and clammy. 
Algid malaria is sometimes associated with a bacterial infection of the blood 
(septicemia) with toxemia and massive gastrointestinal hemorrhage(54). 
Hypotension and shock (algid malaria) are often attributable to secondary 
gram-negative septicemia requiring appropriate antimicrobial therapy and 
hemodynamic resuscitation. Failure to re-hydrate these patients may lead to 
circulatory collapse, lactic acidosis, renal failure and severe 
hyponatremia(55).  
1.2.8.1.Cerebral Malaria (CM): 
Malaria infection of the central nervous system (CNS) can cause a 
severe neurological syndrome termed cerebral malaria(56). Cerebral malaria 
refers to unarousable coma not attributable to any other cause in a patient 
infected with Plasmodium falciparum(41). The neuropathological feature is 
preferential sequestration of parasitised red blood cells (PRBC) in the 
cerebral microvasculature. The mechanism by which PRBC cause coma in 
malaria remain unclear(56).  
 
The development of malaria coma is chiefly associated with 
untimely diagnosis, patients’ late admissions, and inadequate prehospital 
treatment. The current and past diseases may be regarded as factors 
aggravating the disease(57). 
The major players of cerebral malaria potentially include: receptors 
expressed on the surface of the endothelial cell and known to interact with 
infected red blood cells, cytokines modulating the expression of these 
adhesion molecules, nitric oxide (NO) and others(58). Cells other than 
infected red blood cells, such as platelets, monocytes and lymphocytes, have 
the ability to adhere to these endothelial receptors and to one another, via 
different ligands, leading to a more complex situation and an increase in the 
degree of vessel occlusion(58). 
 The most important complication of severe malaria disease is 
cerebral malaria. It is a neurological syndrome consisting of a diffuse, 
potentially rapidly reversible encephalopathy associated with loss of 
consciousness and fitting(59).  
The frequency of cerebral malaria increases with increased child age, 
they found cerebral malaria among 11.3%, 28.2% and 60.6% of children 
aged 0-3 years, 4-7 years and 8-15 years respectively(38). On the other hand 
cerebral malaria develops only in about 2% of patients infected with 
Plasmodium falciparum out of which, mortality rate is 30-50% (1).  
Estimation of the level of consciousness uses the Glasgow coma 
score (or modified Blantyre score for children) to measure responses to 
verbal and painful stimuli, with cerebral malaria defined by a score of less 
than 11/15 (60) .  
The level of consciousness ranges from confusion to stupor to coma. 
The patient can become unconscious very quickly and is unresponsive to 
pain, visual or verbal stimuli. There are often fits, which can be prolonged as 
status epilepticus, but few localizing neurological signs: weakness, 
hemiplegia or cranial nerve defects(59). There have also been reports of a 
specific cerebellar syndrome both during and after disease (61).  
Retinal hemorrhage is associated with a poor prognosis in children 
with cerebral malaria. Fundoscopic examination is not only useful to rule out 
raised intracranial pressure before performing a lumbar puncture, but also a 
useful measure in assessing prognosis in children suffering from cerebral 
malaria(62) . 
The rate of permenant neurological complication was higher than 
originally thought, with up to 10% of patients suffering some sort of 
neurological impairment ranging from weakness and hearing impairment to 
severe symptoms such as quadriplegia, epilepsy and cortical blindness(63,64). 
On the other hand the long-term impact of cerebral malaria on the 
development of children who recover without major neurological sequelae is 
not as serious as had been feared (65).  
The most common forms of neurologic sequelae were paresis and 
ataxia, often found in combination with other neurologic abnormalities. 
Depth of coma on admission, multiple convulsions, and duration of 
unconsciousness were the only three independent risk factors. Hypoglycemia 
and lactate acidosis were not predictive of sequelae, although they are 
important risk factors for fatality(66).  
The overall incidence of post-malaria neurological syndrome 
(PMNS) after falciparum infection was 1.2 per 1000. The syndrome is self 
limiting, median duration 60 hours(67). PMNS was associated with the use of 
oral mefloquine. Similarly, the use of mefloquine, chloroquine, and earlier 
quinacrine for the prophylaxis or treatment of malaria has also been 
associated with an acute self-limiting neuropsychiatric syndrome(68,69). On 
the other hand, concluded that a large number of survivors are left with 
disabling neurological sequelae. Few patients may experience post-malaria 
neurological syndrome after recovery from complicated falciparum 
infection(70).  
Cerebral malaria accounted for 80% of the deaths in malaria 
infection(71). Whereas, in Africa, 10-40% of patients hospitalized with 
cerebral malaria will die, even when treatment is optimal(60), 20% mortality 
of treated cerebral malaria was reported(72).  
In study done in Gambia, they found that a cold periphery, deep 
coma and hypoglycemia were the clinical signs and laboratory parameters 
that predicted death most strongly. More than 90% of children who died had 
at least one of these conditions. Also, children with increased urea levels on 
admission or those who experienced multiple convulsions subsequently were 
more likely to die(73).  
A study of the relationship between the presenting features and outcome 
in 131 Malawian children admitted with cerebral malaria showed that, the 
presenting clinical signs were significantly associated with adverse outcome, 
death or sequelae, profound coma (score = 0/15)? signs of decerebration, 
absence of corneal reflexes, convulsions at the time of admission and age 
under three years. Laboratory findings of prognostic significance were 
hypoglycaemia, leucocytosis (>15.000), hyperparasitaemia, elevated plasma 
concentrations of alanine and                 5-nucleotidase and elevated plasma 
or cerebrospinal fluid lactate. Children having four or more of these 
prognostic indicators had an eight fold higher risk of adverse outcome, than 
those with fewer than four(60,74).                                 
1.2.8.2. Pulmonary Complications of Malaria: 
Pulmonary manifestations are frequently observed in children with 
malaria. The pathophysiology is poorly understood but would appear to be 
secondary to an interaction between the parasitized red cells and the 
pulmonary capillary endothelium. The prevention of pulmonary 
manifestations associated with malaria can easily be accomplished by 
limiting water intake and carefully monitoring urinary output and weight(75).  
Malaria may present with respiratory manifestations. This may be 
misdiagnosed, and important time is lost, that may lead to higher morbidity 
and mortality. It was concluded that malarial atypical respiratory 
presentations are far higher in incidence than reported in literature e.g. 
Bronchitis 15%, asthmatic bronchitis 1% and pneumonia 4%. The main 
presenting symptoms were cough 77%, dyspnea 32%, expectoration 29% 
and chest pain 15% (76).  
Altered pulmonary function in malaria is common, suggested, that 
there may be common underlying inflammatory mechanisms(77).   
The incidence of bronchiolitis up to 18 months of age in the 675 
Tanzanian children was 0.58 episodes per child per year. The proportion of 
children who had bronchiolitis was lower among those who had had malaria 
episodes than among those who had not(78).  
Abnormal respiratory pattern was found in 40% of children with 
cerebral malaria, four distinct patterns were seen: (i) Deep Breathing, 
associated with severe metabolic acidosis. (ii) Hypoventilation.  (iii) 
Hyperventilation.  (iv)  Periodic respiration. Recognition of these patterns 
and rapid initiation of appropriate supportive therapy may help to reduce the 
high mortality rate of this disease. Hypoventilation indicates status 
epilepticus. Hyperventilation indicates varying degrees of intracranial 
hypertension. Periodic respiration indicates transtentorial herniation(79). 
The presence of respiratory distress was found to be the most 
important predictor of death. Children with severe malaria anemia and signs 
of respiratory distress must therefore be transfused as soon as possible(80).  
1.2.8.3. Renal Complications: 
Acute renal failure (ARF) is a common complication in severe 
falciparum malaria. The disorder is usually oliguric or anuric and 
hypercatabolic. Acute tubular necrosis (ATN), the principal pathologic 
lesion in falciparum malaria-induced ARF, is mediated by a complex 
interaction of mechanical, immunological, cytokine, humoral, acute phase 
response, non specific factors, and hemodynamics factors. Sequestration of 
parasitized erythrocytes secondary to reduced renal microvascular blood 
flow express a central role in all Aforementioned pathogenic factors of ARF 
and excavated by hypovolemia and haemoglobinuria (81). 
Renal insufficiency as a complication of severe malaria is a rare 
pathology. Clinical features include severe anemia, oligo-anuria, and 
creatinemia. They added; renal functions of the child affected by severe 
Plasmodium malarial fever must always be checked (82). 
 
 
1.2.8.4. Hypoglycemia: 
Hypoglycemia is frequently found in children with cerebral malaria. 
It is associated with appropriately low plasma insulin concentrations and is 
commonly accompanied by hyperlactataemia (83, 84). 
Hypoglycaemia is not due to hyperinsulinaemia which is evident by 
the low plasma insulin level (83). 
Children are more likely than adults to develop hypoglycaemia, and 
may become hypoglycaemia solely as a result of fasting, particularly during 
any illness accompanied by fever and vomiting. They added that the 
frequency of hypoglycemia did not differ significantly between malarial and 
control patients(85). 
Hypoglycaemia (whole blood glucose < 2.2 mmoL/L) commonly 
complicates Severe malaria in children in 13-32% of cases (60), and is 
associated with an increased risk of death or suffering sequaelae from the 
illness(83, 84).  
Hypoglycemia is particularly common in young children              (<3 
years old), in those with convulsions or hyperparasitaemia, and in patients 
with profound coma. It is associated with lethal convulsions, lactic acidosis, 
and high concentrations of circulating tumor necrosis factor(35).  
Hypoglycaemia may recur during treatment of severe malaria; these 
recurrences are commonly due to the disease (plasma insulin concentrations 
are appropriately low) but quinine-induced hyperinsulinaemia may 
contribute to recurrent hypoglycaemia in some cases(35).  
Impairment of hepatic gluconeogenesis remains the most likely 
mechanism for hypoglycaemia in severe childhood malaria, although its 
pathogenesis is unknown(35).  
Hypoglycaemia was a frequent complication; it complicates up to 
12% and associated with poor prognosis. It is also possible to improve 
severe malaria prognosis by improvement and early management of 
hypoglycaemia(86). 
1.2.9 Immunological aspects of malaria:  
1.2.9.1. Haptoglobin 
Haptoglobin is an acute phase protein, which forms 1% of the 
plasma protein mass. It binds free hemoglobin released by intravascular 
hemolysis, forming a stable hemoglobin-haptoglobin complex, which is 
transported to the liver and degraded. The purpose of this may be to prevent 
loss of free hemoglobin and thus iron from the body through the kidneys(87).  
Haptoglobin is a tetramer, composed of 2α and 2β chains, linked 
together by disulphide bonds. The β chains have an invariant primary 
structure, whereas, variations in the primary structure of the α chain result in 
the existence of 3 phenotypes ‘1-1’, ‘2-1’ and ‘2-2’ (88).  
The three haptoglobin phenotypes could be visualized by benzidine 
staining after application as a dilution series on the gels down to a 
concentration of 100 ng per 5µL sample i.e. equivalent to 0.02g/L(89) . 
The levels of haptoglobin and many other acute phase proteins, such 
as C-reactive protein, fluctuate during acute Falciparum malaria and have 
been used as indirect measure of the effectiveness of malaria control 
programs(90, 91) .  
There was an increased frequency of clinical symptoms of malaria 
attacks among individuals with haptoglobin phenotype ‘1-1’ (89).  
The haptoglobin (Hp) phenotypes are determined by polyarcylamide-
gel electrophoresis in plasma. Samples obtained from 113 plasmodium 
falciparum malaria patients (aged 1-12 years) with strictly defined cerebral 
malaria (CM), severe malaria anemia (SA), or uncomplicated malaria (UM) 
and 42 ages matched healthy controls from the same area (coastal Ghana). 
Hp1-1 was significantly more prevalent among patients (43%) than among 
healthy controls (7.1%), whereas Hp2-1 and Hp2-2 were under represented 
among the patients (11% and 2%, respectively) compared to the control 
donors (33% and 14%, respectively). No significant difference in frequency 
of HpO was observed between patients and controls. Among the malaria 
patients, the Hp1-1 phenotype was significantly more prevalent among 
patients with (CM) and (SA) as compared to patients with uncomplicated 
disease. Whereas, the reverse was seen with respect to Hp2-1 and Hp2-2. 
The data suggest that the Hp1-1 phenotype is associated with susceptibility 
to Plasmodium falciparum malaria in general and to the development of 
severe disease in particular(92). On the other hand, the influence of 
haptoglobin polymorphism on severe malaria occurrence was assessed in 
1183 individuals from Gambia. No significant association was found 
between severe malaria and either haptoglobin genotypes or phenotypes(93).  
The association of haptoglobin phenotype ‘1-1’ with falciparum 
malaria and cerebral complications suggests a role for haptoglobin in the 
modulation of the pathophysiology of the disease. This involves cytokine 
release by the host, release of toxins by the parasite, and sequestration of 
parasitized cells in the microvasculature(94, 95).  
There is no association observed between ahaptoblobinemia and 
parasitemia(96). Haptoglobin negatively correlated with parasitemia, but did 
not appear to be useful episode marker(33). The  parasitemia does not 
significantly correlate with haptoglobin concentration. However, 
haptoglobin can be useful to assess at community level the impact of 
intervention on parasitemia(34).  
Hypo-or ahaptoglobinemia, a common phenomenon in tropical 
countries, is mainly due to malaria induced hemolysis(97). Low serum 
concentrations of haptoglobin are found in semi-immune and non-immune 
patients(98). Repeated malaria attacks cause ahaptoglobinemi (99).  
Both soluble hemoglobin and haptoglobin appear to be markers of 
recent Plasmodium falciparum infection(100).  
Reduced haptoglobin levels <180 mg/L indicates malaria-induced 
intravascular hemolysis. C-reactive protein and haptoglobin are simple and 
inexpensive to measure in large numbers of people, and they could be useful 
for the assessment of malaria intervention programs(91).  
1.2.9.2. Cytokines: 
Tumor necrosis factor (TNFα), a cytokine produced by monocytes, 
macrophages and T lymphocytes, plays an important role in host response to 
inflammation and infection.   
Cytokines, including (TNF-α), may protect against malaria by 
stimulating host immune responses to the parasite. However, cytokines may 
also contribute to the immunopathological complications of malaria(101).   
TNF-α secretion is induced by phosphatidylinositol (PI)  containing 
agents secreted by malaria parasite(102).  
Protection against pathogenic concentrations of cytokines may be 
achieved by production of cytokines antagonists, which block the activity of 
the cytokine, or by production of factors such as antibodies capable of 
blocking the activity of cytokine-inducing agents. Antibodies against PI 
block TNF-α secretion induced by malaria parasite(103).   
Patients with malaria show raised levels of TNFα with possible 
relation of TNFα to severe and cerebral malaria(104).  
Proinflammatory cytokines and particularly TNFα contibute to 
severe disease(48). 
TNFα levels are elevated with falciparum malaria, and they are not 
specific to cerebral malaria infection, as reported in other studies(47).  TNFα 
and Interleukin (IL-10) were significantly elevated in children with high-
density parasitemia and malaria anemia compared with children not 
infected(105).  
Severely anemic children with Plasmodium falciparum infection 
have low plasma TNFα levels, in contrast to the high levels found in cerebral 
malaria. These findings suggest that severe malarial anemia and cerebral 
malaria are influenced by separate genetic factors situated near the TNF 
gene(106).  
1.2.9.3. Immunity against Malaria: 
Activation of the immune system in malaria plays an important role 
in both defense against parasites and pathogenesis.  
Cytokines such as interferon-gamma (IFN-γ) and TNF-α are 
involved in the pathogenesis of murine cerebral malaria(101,107,108). The host’s 
immunological response could contribute to the pathophysiology of malaria 
complication in human beings. Cytokines are implicated in the 
pathophysiology of survival and fatal outcome in severe infections(109).  
 In humans, serum concentrations of TNF-α are associated with the 
fatal outcome of malaria(110). It is uncertain what mediates protection against 
malaria in humans, but certain molecules and antirosetting antibodies have 
been associated with protection against severe malaria(111,112). Antibodies 
reactive to several different antigens and T cell reactivity to merozoite 
surface protein-1 have been associated with protection against clinical 
disease. Therefore, regulation of the activity of different subsets of the 
immune system during the infection could determine the clinical 
outcome(113,114,115). 
Nitric oxide (NO) is known to play a protective role against clinical 
malaria. Niric oxide levels were high in severe anaemia which suggest the 
hypothesis that immune – mediated erythrocyte destruction is involved in 
the pathogenesis of malarial anemia(109). 
1.2.10.Vitamin A and Malaria: 
Vitamin A deficiency increases the risk of illness, while infections 
impair vitamin A status. Serum retinol negatively correlates with malaria 
parasite count and to serum levels of CRP and alpha-1- acid glycoprotein 
(AGP). Increased malaria parasite density resulted in raised CRP and AGP 
levels, which were negatively associated with serum retinol(116). 
1.2.11. Congenital malaria: 
Congenital malaria is defined as the presence of Plasmodium 
parasites in the erythrocytes of newborns less than seven days old(117). 
Congenital malaria should always be considered in a febrile or ill 
neonate(118).  
Pregnancy can make women more susceptible to infection with 
malaria and might allow a sufficient increase in the density of parasitemia 
that leads to passage of parasites through the placenta to the fetus(119).  
 A study in Togo differentiated between two forms of congenital 
malaria, congenital malaria disease (CMD) and congenital malaria 
infestations (CMI). CMD was diagnosed when clinical manifestations were 
associated with positive thick and thin blood films in a mother and her 
newborn. The diagnosis of CMI was retained when despite positive 
parasitemia, no clinical manifestations were observed(120).  
The parasite densities in the babies were not proportional to maternal 
load and were generally low, although higher in the low socioeconomic 
group. Their study revealed that 29% of mothers from low socio-economic 
group and 11% of their babies had malaria parasitaemia. The corresponding 
figures for middle and high socioeconomic groups were 15% and 7%, 
respectively(121).  
Malaria in the neonate should be confirmed using Giemsa-stained 
thick and thin blood smears. If the infant’s smear is positive for malaria 
parasites, the mother’s smears also should be examined for malaria parasite. 
If the mother’s smears are negative, then serologic analysis of her blood for 
Plasmodium species antibodies should be conducted(122). 
1.2.12.  Malaria situation in Yemen: 
1.2.12.1. Prevalence and magnitude of the problem: 
A longitudinal survey on malaria was conducted in the foothill 
(Wadi Rissian) in an area between 450m-750m elevation South - West of 
Taez in Yemen Arab Republic. It was found that malaria is mesoendemic 
and transmission is perennial. Plasmodium falciparum is the only parasite 
species identified and Anopheline arabiensis the main vector collected(123).  
There are three anopheline species found in Yemen. Anopheles 
arabiensis was the most prevalent species (84.2) with a sporozoite rate of 
0.7%, followed by Anopheles culicifacies adenesis (14.9) and Anopheles 
rhodesiensis rupicolus (0.9%). Maximum indoor resting density was 
recorded during March, July and August (124).  
About 60% of the total population live in endemic malaria areas (at 
risk all through the year), 20% in areas where malaria is seasonal, 20% in 
malaria free areas or slightly affected by the disease (125).  
Study done shows that 50-60% of the total population is at risk, and 
children under five and pregnant women are the major victims of malaria in 
Yemen(126). The incidence of malaria is 1.500.000 cases occurred 
annually(125). whereas in other study the estimated figure is 1.800.000(15). 
Both studies reported fatality rate of 1% mostly among children. 
In the Eastern Mediterranean region about 45% of the population 
live under the risk of both Falciparum and vivax malaria, and additional 
15% under the risk of Plasmodium vivax alone (8) . The estimated annual 
number of malaria cases is about 14 million, out of which 95% occur in four 
countries: Afghanistan, Somalia, Sudan and Yemen.  
Malaria in Yemen is epidemiologically classified as “Afrotropical” 
which is the worst epidemiological malaria situation worldwide. More than 
90% of the total malaria cases were due to Plasmodium falciparum, the 
remaining 10% is divided between plasmodium malaria and Plasmodium 
vivax 7-3% accordingly. The main malaria vector is Anopheles Arabiansis 
followed by Anopheles cuilicasis(125,126).  
The endemicity is not the same all over the country. It is meso to 
hyper-endemic along the coastal belt (with a length of 2000 Km and a 
breadth of 30-60 Km). This extends from the Yemeni-Omani border in the 
east to Bab-Al-Mandab in the west along the Indian ocean, and from Bab-
Al-Mandab to the Yemeni-Saudi border in the north along the red sea (about 
500 Km), where the season of transmission is mainly during winter i.e. from 
October to March. It is meso or hyper-endemic in the foothills and middle 
highest (400-2000 meters high) where the transmission is all the year round 
or following the rainy season (during summer), while it is almost malaria 
free in the mountainous area above 2000 meters high. It is also malaria free 
in the deserts (Al-Robea-Alkhali). Malaria is meso to hyper-endemic in 
Socotra Island where the transmission season is also from October to March 
or April, while it is too windy and dry from May to August in the Island (15).  
1.2.12.2. Malaria Control in Yemen: 
During the years 1994 to 1997 the NMCP was plagued by many 
difficulties which affected its control measures in general and vector control 
in particular. This led to an increase in malaria cases due to epidemics 
occurring here and there, and now and then. The main difficulties are lack of 
transportation, inadequate support and finance, lack of administration 
connections between the Sanaa health office and the primary units at 
governorate level and high turnover of technical and trained personnel (125).  
Malaria is a major impediment of development both socially and 
economically. By the year 2000, formation of the Supreme National malaria 
Control Committee occurred. The year 2001 was announced as a year of 
Roll Back malaria. A new National Malaria Control Centre has been 
recently established in Sana’a for planning, monitoring, follow-up, training 
and evaluation for the whole country. Examples of success started to 
emerge. A great success has been achieved in Socotra Island where the 
citizens already reported a major and significant decline in the incidence of 
malaria after a successful start of a well organized anti-malaria control 
program in the Island during the last quarter of the year 2000. So, the Roll 
Back malaria program in Yemen is going to succeed(15).  
1.2.12.3. Principles of Roll Back Malaria in Yemen: 
1. Political commitment. 
2. Intersectoral collaboration. 
3. Health education. 
4. Community participation. 
5. Partnership with international organization and NGOs. A special 
collaboration is existing between the Ministry of Health of the Republic of 
Yemen and the WHO (15).  
1.2.13. investigations and Diagnosis of malaria infection: 
The diagnosis of malaria is based on the clinical symptoms, findings 
and laboratory tests. Clinical diagnosis must be considered in all febrile 
patients who have traveled to or lived in malaria-endemic areas. 
The diagnosis of malaria in laboratory is by detecting, identifying 
malarial parasites microscopically. Blood sample should be collected before 
the patient received any antimalarial drugs. Malarial blood films are best 
prepared directly from capillary blood. Anti-coagulated EDTA-blood can 
also be used. Thick & thin films should be prepared as soon as possible. 
Although there are different staining techniques used for staining the film, 
Giemsa stain is considered the gold standared method. 
It is fast, cost effective, reliable and differentiates between species of 
malaria parasites(127,128). Considerable overlap exists between malaria and 
other diseases, especially acute lower respiratory tract infection and 
bacteremia (129).  
A modification of light microscope, the quantitative Buffy coat 
method (QBCTM, Becton Dickinson) was developed to screen large numbers 
of specimens for complete blood cell count (130). Adapted for malaria 
diagnosis, it involves the use of a special fluorescent stain to highlight 
malaria parasites and centrifugation to concentrate parasites at a predictable 
location on a specially prepared capillary tube. The advantages of QBC: less 
training is required, it is quicker to perform and it is marginally more 
sensitive than conventional microscopy. The disadvantages: electricity is 
always required; it needs special equipment and supplies (131,132).  
Another diagnostic approach involves the rapid detection of parasite 
antigens, usually through enzyme-linked immunosorbent assay (ELISA) and 
radioimmunoassay (RIA) techniques (133).  
1.2.13.1.The Rapid Manual ParaSightTM- F Test: 
This method depend on the detection of the antigen trophozoite 
(ParaSightTM-F of falciparum species malaria). Advantages of this method 
are that; no special equipment is required, reagent are stable at normal 
temperature and no electricity is needed(134,135,136,137,138). The principle 
disadvantages are a high per test cost. The test is restricted for P falciparum 
only and non  quantative. In addition a false positive result can be persisted 
for 10 to 14 days after treatment and cure(139,140,141).  
1.2.13.2. Diagnosis by Polymerase Chain Reaction (PCR): 
Detection of parasite genetic material through polymerase chain 
reaction (PCR) techniques has gained a growing role in the diagnosis of 
malaria. Specific primers have been developed for each of the four species 
of human malaria. One important use of this new technology is in detecting 
mixed infections or differentiating between infecting species when 
microscopic examination is inconclusive (142).  
In places where transmission of both Plasmodium vivax and 
Plasmodium falciparum occurs, nested PCR detection of malaria parasites 
could be a very useful complement to microscopical diagnosis. They added, 
the results obtained by PCR are equivalent or superior to those obtained by 
microscopy. All microscopy positive samples were positive by PCR. The 
PCR were able to detect mixed infections that were missed by 
microscopy(143). On the other hand, the PCR assays are the most sensitive 
and specific method for malaria parasite(144).  
1.2.13.3. Automated Depolarization Analysis: 
The emerging role of malaria pigment (hemozoin) detection by 
automated depolarization analysis using Cell-Dyn 3200 and Cell-Dyn 3700, 
is a new tool for malaria diagnosis. It depends on the relationship between 
depolarization patterns and clinical presence/absence of malaria(145).  
1.2.13.4. Parasite density (parasitemia): 
Giemsa-stained blood films were routinely used for detection of 
parasites. In this study, both thin and thick blood films were prepared in 
order to determine the parasitemia. Thick and thin films were interpreted as 
negative only after examination with an oil immersion lens at X 1.000 
magnification for at least 100 oil immersion fields by an expert 
microscopist. If there was still uncertainty the test was repeated after 12 
hours for 48 hours. All the samples were air-dried, fixed in methanol and 
then stained for 15-30 minutes in Giemsa; a 1:10 diluted Giemsa (pH 7.2) 
was used. The stain was washed off with tap water and the smear was 
examined by X 1.000 magnification. The percentage of the parasitemia was 
calculated as the total count of infected red blood corpuscles (RBCs) per 100 
counted in Giemsa stain thin blood film. 
% Parasitemia = number of infected RBCs X 100/ Total number of RBCs   
The parasite load was estimated to range from mild to severe on a 
scale of 1-4, corresponding approximately to <5%, 5% - 10%, >10% - 20% 
and > 20%, respectively. 
1.2.14. Prevention of Malaria: 
Malaria prevention consists of reducing exposures to infected 
mosquito and using chemo-prophylaxis. 
Personal protection therefore remains the choice method for disease 
prevention and can usefully complete chemoprophylaxis if available, while 
there are still no vaccines (146).  
1.2.14.1. Personal protection: 
Personal protection can be ensured by three main methods: avoiding 
risky areas; using pyrethroids insecticide on garments (permethrin), 
mosquito nets (several pyrethroids available) and any other materials 
(curtains…. etc) including camping tents, plastic "UN sheeting" used in 
refugees camps …..etc. 
Repellent gave some protection for few hours (not more 6 hours) and 
new formulations have been developed to extend their duration. Great care 
must be taken when using diethyltoluamide (DEET), which is not 
recommended for children and pregnant women(146). If it is absolutely 
necessary to use DEET in a 10-15% solution for children, it should be 
applied to exposed areas except the eyes, mouth, or hands and then 
immediately washed off as the child goes back inside (147).  
 Synthetic pyrethroids are the only compounds currently available 
which are suitable for treating nets because of their long residual effect on 
the netting and their very low toxicity to human(148).  
Several field trials have evaluated the effectiveness of insecticide-
treated nets in preventing malaria infection and disease(149).  
Most of the trials defined a case of clinical malaria as a documented 
history of fever in association with P. falciparum parasitaemia. The age 
groups included in the trials, and the type and dosage of insecticide varied. 
Some trials compared treated nets with non-treated nets while others 
compared treated nets with no nets. 
Few selected controlled field trials have been conducted in Africa 
and Asia after publication of the CDC meta-analysis. The duration and age 
group of these trials varied(150,151,152,153,154).    
On the basis of this evidence, the ability of treated nets to reduce the 
number of disease episodes in communities with stable malaria in Asia and 
Africa are no longer be questioned. 
Insecticide-treated nets affect the children growth, and/or 
haematocrite or hemoglobin in children sleeping under treated nets as 
compared with control children (150).  
Many field studies have ducomented a much higher impact of 
insecticide-treated nets on child mortality (155,156,157).  
The demonstration of the effectiveness of residual house spraying of 
the insecticide DDT (dichoro-dighenyl-trichlorothane) in killing mosquitoes, 
and successes in eradicating malaria from parts of Europe and the US where 
it was endemic, led to enthusiasm for worldwide malaria eradication in the 
1995s(158). 
A Global Malaria Eradication campaign 1955 based on the 
widespread use of DDT against mosquitoes and elimination of the parasite in 
human eradicated malaria by 1967 from all developed countries where the 
disease was endemic. Global Malaria control strategy 1992 differs 
considerably from the approach used in eradication era, based on disease 
rather than parasite control(159).  
1.2.14.2 Malaria chemoprophylaxis: 
Chemoprophylaxis is necessary for all visitors to and residents of the 
tropics who have not lived there since infancy. Children of non-immune 
women should have chemoprophylaxis from birth (160).  
Prophylactic chemoprophylaxis has been shown to be extremely 
effective but not a replacement for other protective measures(147). None of 
the chemoprophylaxis drug regimens guarantees complete protection against 
malaria. Resistance of P. falciparum to the traditional chemoprophylactic 
agent, chloroquine, is rapidly increasing worldwide(161). Because of this 
growing problem of resistance, other agents are increasingly used. 
Mefloquine, a synthetic 4-Quinloine related to chloroquine is highly 
effective against chloroquine-resistant P. falciparum(162,163). Proguanil 
(Paludrine) is recommended by some authorities for prophylaxis against 
chloroquine-resistant P. falciparum in East Africa, especially for children 
weighing less than 15kg. It should only be sued in combination with weekly 
chloroquine phosphate(164).  
Primaquine is given to prevent relapses of malaria that occur with P. 
vivax and P. ovale infection(165).  
1.2.14.3. Malaria vaccine:  
A vaccine is a substance that causes the immune system to develop 
responses that protect against a specific disease. 
The vaccine (NANP) 3-TT is a synthetic peptide of the 
circumsporozoite protein (CS) of Plasmodium falciparum coupled to tetanus 
toxoid (TT) as protein carrier and adsorbed to aluminum hydroxide as 
adjuvant. Study done on the vaccine (NANP) 3-TT found no systemic 
reaction to the vaccine in infants either immediately or during the 5 months 
follow-up period. Minor local tumefactions were observed in only 3% of the 
children. The vaccine was found to be immunogenic with a peak IgG 
response at day 75 (four times that seen at day 0), however, it was for a short 
duration(166) .  
The vaccine stimulates antibody and T-cell responses that can respond 
quickly to the infection and prevent the invader from causing serious 
clinical disease. An ideal malaria vaccine should prevent all infections by 
priming the immune system to destroy all parasites, whether free 
swimming in the blood, in the liver, or even, theoretically, while in red 
blood cells. This degree of protection would be extremely difficult to 
achieve and might not be technically feasible with current vaccinology art 
and science. Many vaccine developers have therefore focused their efforts 
on creating a vaccine that limits the ability of the parasite to successfully 
infect large numbers of red blood cells(167) . If the pre-erythrocytic vaccine 
is 100% effective, the host will suffer no malaria disease. This type of 
vaccine might be most useful to people traveling to malaria endemic 
countries. If, however, a pre-erythrocytic vaccine is less than completely 
effective and even a single sporozoite emerges from the liver, the host will 
develop full-blown malaria. Despite this, there is some evidence that if the 
number of sporozoites that reach the liver is reduced, resulting disease 
might be less severe. 
A vaccine that contains blood stage antigens will mimic the 
immunity that develops in people living in malaria endemic areas. This 
immune system will be focused in such a way as to impact the merozoit as it 
contains in its replicative cycle. The host would still get malaria and still get 
sick, but the severity and lethality of the disease would be reduced. This is 
the type of vaccine that might be most appropriate for children and adults 
living in endemic countries. Transmission blocking vaccine will prevent the 
host from getting malaria, nor will they lessen the symptoms of disease. 
They will, however, prevent any mosquitoes that feed on the host from 
spreading malaria to new hosts(168) .  
The peptide-based vaccines offer several potential advantages over 
the conventional whole proteins (or whole gene, in the case of genetic 
immunization) in terms of purity and a high specificity in eliciting immune 
responses. However, concerns about toxic adjuvant, which are critical for 
immunogenicity of synthetic peptides, still remain. Lipopeptides, a form of 
peptide vaccine, discovered more than one decade ago, are currently under 
intensive investigation because they can generate comprehensive immune 
responses, without the use of adjuvants. The recent development of mucosal 
application of lipopeptide vaccines may present an ideal strategy against 
many pathogens that infect mucosal surfaces(169) .  
1.2.15. Treatment of malaria: 
There are a limited number of drugs available for treatment or 
prevention of malaria. Because of rapidly developing and spreading 
resistance to antimalarials, the number of useful drugs is dwindling(170) . 
 
 
The currently available antimalarial drugs are: 
• Quinine: quinine and its dextroisomer, quinidine, are rapidly acting drugs 
that target the erythrocytic asexual stages of all malaria parasites. It is 
available in both oral and parenteral preparations and can be used in 
infants and pregnant women(171,172). Side effects include nausea, 
dysphoria, blurred vision and tennitus (cinchonism) and resolve after 
ending the treatment(173). Plasmodium falciparum responds well to 
quinine, so, shortened courses of quinine can be used in conjunction with 
a second drug to reduce its side effects. On the other hand, Plasmodium 
falciparum from southeast Asia require full course quinine treatment in 
conjunction with a second drug(171,172) . The majority of deaths from 
cerebral malaria occur within 48 hours after admission to hospital, 
because of the possibility of inadequate treatment within this period. A 
loading dose of Quinine (20 mg/kg) was associated with faster recovery 
from coma and enhanced clearance of parasitemia and fever, together 
with lower mortality and higher hemoglobin levels(174) .  
• Chloroquine (4-aminoquinoline): It was used as drug of choice for the 
treatment of non-severe or uncomplicated malaria and for 
chemoprophylaxis. Chloroquine acts against erythrocytic asexual stages in 
addition to gametocytocidal properties. Its usefulness is increasingly 
limited because of widespread resistance. It can be used for treatment and 
prophylaxis of infants and children. Side effects are uncommon and 
include headache, gastrointestinal troubles and blurred vision. Dark 
skinned population experience pruritus(171,172) . 
• Amodiaquine: because of frequent adverse reactions, it has fallen out of 
favor. Amodiaquine may be useful in settings of very low-level 
chloroquine resistance(50) .  
• Antifol Combination Drugs: are combinations of dihydrofolate 
reductase inhibitors (proguanil, chloroproguanil, pyrimethamine, and 
trimethoprim) and sulfa drugs (dapson, sulfalene, sulfamethoxazole and 
sulfadoxin. Parasitological resistance can develop when used alone. When 
used in combination, synergistic effect and effectiveness occur even if 
resistance to individual compound is present. Typical combinations 
include sulfadoxine/pyrimethamine, sulfalene/ pyrimethamine and 
sulfamethoxazole/ trimethoprim(175) . The use of folate supplementation 
may increase the frequency of treatment failure with antifol combination 
drugs(176) .  
• Tetracyclines: tetracycline and derivatives such as doxycycline are very 
potent antimalarial drugs as treatment and prophylaxis. Tetracyclines are 
used with quinine to improve cure rates. They can be used with shortened 
courses of quinine to decrease quinine-associated side effects. 
Tetracyclines should not be used during pregnancy or breast-feeding or in 
children less than 8 years because they can disrupt teeth and bone 
development(173) .  
• Primaquine: primaquine has good efficacy when used for 
prophylaxis(165). Primaquine should not be used in pregnancy because they 
cross the placenta and cause hemolytic anemia in a G6PD-deficient 
fetus(50) .  
• Mefloquine: it is a quinoline-methanol derivative of quinine. It can be 
used either therapeutically or prophylactically in most areas with 
chloroquine resistant malaria. Mefloquine is difficult to be used in small 
children because it frequently causes vomiting and because no pediatric 
formulation is available(163) .  
• Halofantrine: it is a phenanthrene-methanol compound with activity 
against the erythrocytic stages of the malaria parasite. It is recommended 
in areas with chloroquine-resistant falciparum. The drug can cause cardiac 
conduction abnormalities, which limits its usefulness(177). Cardiac 
abnormalities are dose dependent, and electrocardiography is 
recommended prior to treatment(178). It should be given on an empty 
stomach. Fatty foods increase absorption, increase the drug’s anti-
parasitic activity but increase the risk of cardiac complications. Re-
treatment of patients who had failed mefloquine therapy with halofantrine 
is less successful than primary treatment with halofantrine, suggesting 
cross-resistance between the two drugs(179) .  
• Clindamycin: it has limited antimalarial activity. Recrudescence are high 
following clindamycin alone, but combined with quinine, it may be useful 
in the treatment of pregnant or young children. However more effective 
drugs are available to be used instead(180) .  
• Artemisinin Compounds: these compounds are used for treatment of 
severe malaria with very rapid parasite clearance times and faster fever 
resolution than occurs with quinine. Also, there is quicker improvement of 
coma with artemisinins(181). When used alone, especially for duration of 5 
days or less, recrudescence rates are high, so, they are most frequently 
used in combination with mefloquine(182).  
• Atovaquone: it is hydroxynaphthoquinone that is currently being used for 
treatment of opportunistic infections in immunosuppressed patients. It is 
effective against chloroquine-resistant plasmodium falciparum, but 
because of a high incidence of recrudescence, atovaquone is usually given 
in combination with proguanil(164,183) . Treatment is usually with 1000 mg 
atovaquine and 400 mg proguanil daily for 3 days, which is effective 
against erythrocytic forms of all four species of human malaria(164,184) .  
• Pyronaridine: it is a drug that has been synthesized and used in China for 
over 20 years. While the drug was reported 100% effective in one trial in 
Cameroon, it was found only 63-88% effective in Thailand(185,186). 
The choice of treatment will depend on the infecting species, the 
density of infection, the presence or absence of complications, the possibility 
of resistance and the drugs that are available in the country. Patients infected 
with Plasmodium vivax, Plasmodium ovale or plasmodium malariae and 
patients with uncomplicated Plasmodium falciparum in areas where drug 
resistance has not been documented should be treated with a 3-day course of 
oral chloroquine(187). The traditional 3-day course of treatment with 
chloroquine can be compressed into 36 hours(188). A 14-day course of 
primaquine should also be given to patients infected with Plasmodium vivax 
or Plasmodium ovale to eradicate dormant liver stage (hypnozoites). Some 
strains of Plasmodium vivax from Southeast Asia appear less susceptible to 
primaquine and may require larger doses or a longer duration of therapy(187). 
1.2.15.1. Combination Therapy: 
For uncomplicated Plasmodium falciparum where drug resistance 
has been documented, the recommended regimens include quinine combined 
with tetracycline or sulfadoxine-pyrimethamine, mefloquine alone, or 
halofantrine alone(170,180). The combination of artesunate, given for 3 days, 
and mefloquine is now the treatment of choice for uncomplicated multidrug-
resistant falciparum malaria. In combination with artesunate, mefloquine 
administration should be delayed until the second or third day after 
presentation(189).  
In a study done in Bissau, dose of 50 mg/kg of chloroquine could be 
recommended for treatment of Plasmodium falciparum malaria in Bissau. 
To minimize the risk of side effects, this higher dose should be given 
divided into two daily doses over a three-day period(190).  
On the other hand the chloroquine should no longer be considered 
satisfactory for treating clinically manifest falciparum malaria in children, 
pregnant women and non-immune persons. Chloroquine is being 
increasingly replaced by sulfadoxine/pyrimethamine in order to combat 
uncomplicated malaria, but clinical failure following the use of this 
combination can be expected sooner or later. There is a clear need to look 
beyond sulfadoxine /pyrimethamine and to identify suitable alternatives(161).  
The drug combinations for the treatment of patients suffering from 
uncomplicated falciparum malaria include quinine-tetracycline for 7 days, or 
sequential treatment of artesunate (600 mg given over 5 days) followed by 
mefloquine (1.25 mg divided into 2 doses 6 hours apart) are recommended. 
The sequential treatment is highly recommended for those who failed other 
treatment regimens. Other combinations such as a short course sequential 
treatment of artesunate (300 mg given over 2.5 days) followed by a single 
dose of 750 mg mefloquine or a combination of mefloquine 1.25 mg 
together with tetracycline 1 g per day or doxycycline 200 mg per day for 7 
days are alternative treatment regimens with acceptable cure rate(191).  
Parental therapy is recommended for falciparum malaria when CNS 
or renal complications are present or when there is a high-density infection 
(more than 5% of the RBCs are infected). Plasmodium falciparum infection 
without chloroquine resistance may be treated with intravenous chloroquine. 
In addition to parenteral therapy, exchange transfusion is recommended 
when cerebral malaria, renal failure, or very high-density (more than 10% of 
RBCs infected) infection is present(192). 
1.2.15.2. Children and Pregnant Women: 
Treatment options are more limited for children and pregnant 
women(50). Tetracyclines cannot be used in pregnancy or in children less 
than 8 years old. Primaquine is contraindicated for pregnant women because 
of risk of hemolysis in the fetus. Mefloquine can be used in children who 
weigh less than 15 kg, although infants may be more likely to vomit 
following treatment(163).  
In a study (randomized chemotherapy trial) comparing the 
recommended 1st-2nd-3rd line drug regimen as well as mefloquine, for 
uncomplicated falciparum malaria in Bangladesh, The regimen were 
chloroquine for 3 days (Q, group I), quinine sulphate for 3 days followed by 
single dose sulfadoxine-pyrimethamine (Q3+SP, group II), quinine for 7 
days (Q7, group III), mefloquine 20 mg/kg single dose (MEF, group IV). 
Subjects were symptomatic patients, aged ≤12 years. Early treatment failure 
occurred only in the chloroquine group. RII and RIII parasitological failures 
occurred in 56%, 12%, 8% and 14% in group          I-IV, respectively. There 
were significantly more clinical and parasitological failure with chloroquine 
than with Q3+SP, which we now recommended as a better choice for first 
line therapy(193).  
1.2.15.3. Summary of drugs used to treat malaria:(194) 
Drug Adult Dosage Pediatric Dosage 
Uncomplicated Plasmodium falciparum in areas without chloroquine 
resistance and Plasmodium malariae 
(i) chloroquine phosphate 600 mg immediately, 
followed by 300 mg in 
6-8 hr, then 300mg 
daily for 2 days 
10 mg/kg immediately, 
followed by 5 mg/kg 
in 6-8 hr, then 5 mg/kg 
daily for 2 days. 
Plasmodium vivax or Plasmodium ovale 
(i) chloroquine phosphate As above As above 
          And 
Primaquine phosphate 15 mg daily for 14 days 0.3 mg/kg daily for 14
days 
Uncomplicated Plasmodium falciparum in areas with chloroquine resistance 
(i) Quinine sulfate 
        And 
650 mg three times 
daily for 3 to 7 days 
 
Tetracycline 250 mg qid orally for 
7 days 
5 mg/kg for 7 days 
(ii) 
Pyrimethamine/sulfadoxine 
3 tablets, single dose <1yr: ¼ tablet single 
dose 
  1-3yr: ½ tablet 
  4-8yr: 1 tablet 
  9-14yr: 2 tablets 
  >14yr: 3 tablets 
(iii) Mefloquine 15 mg/kg, single dose Same 
(iv) Artesunate 
         
        And 
4 mg/kg, followed by 
2 mg/kg daily once 
daily for 3 days 
Same 
Mefloquine 15 mg/kg, single dose Same 
Severe Plasmodium falciparum malaria 
(i) Quinine gluconate 
 
 
 
        And 
10 mg/kg loading dose 
IV over 1-2 hr, then 
0.02 mg/kg/min 
continuous infusion 
until oral therapy can be 
started 
Same 
Tetracycline As above As above 
*Adapted from Bloland and Campbell, 1992 
 
1.2.15.4. Therapeutic Efficacy: 
Medicines are losing the battle: 
The absence of a vaccine in the foreseeable future, drugs are, and 
will continue to be, a major tool for malaria control. However, current 
medicines are losing the battle against malaria. Drugs for treating infection 
and controlling the symptoms of malaria are losing their efficacy as the 
malaria parasite is slowly but surely building up resistance to them. New 
drugs, which are affordable to communities in areas of high malaria 
transmission, are urgently needed if the impact of malaria is to be 
contained(13). 
Clinical responses were classified as follows: 
(i) Early clinical failure, if the symptoms persisted or deteriorated within   
the first three days in the presence of parasitemia. 
(ii) Late clinical failure, if there was a recurrence of symptoms and fever 
with a measurable axillary temperature of 37.5°C or above on the 
fourth day or later in the presence of parasitemia; and 
(iii) Adequate clinical response if the symptoms cleared within the 1st 3 
days, irrespective of the presence of parasitemia, and did not recur. 
Parasitological failure was defined as the presence of asexual 
parasites on day 7 or day 14. The responses were classified as RIII or RII 
resistance if the parasite densities on day three were at least 25% or less than 
25% respectively of the initial parasitemia, i.e. on day O and remained 
positive on day 7 or as RI resistance if the parasitemia cleared on day 7 but 
reappeared on day 14. The absence of parasitemia on day 7 and day 14 was 
classified as the S response(161).  
The criteria of drug resistance were absence of clearance of 
parasitemia and/or persistence of fever after 72 hours of therapy(195). 
The first well-documented case of chloroquine resistant Plasmodium 
falciparum from a nearby region, Africa, was reported from Kenya in 1979, 
in a tourist(196).  
P. falciparum is increasing worldwide due to an increase of 
development of resistance to the available antimalarial(197,198). in 1967 the 
World Health Organization developed clinical criteria for the definition of 
resistance(199). In vitro tests for chloroquine-resistant P. falciparunm 
correlated well with the clinical criteria, including those tests performed in 
the field(200). Infection with chloroquine-resistant P. falciparum and its 
spread occurs either by local transmission and migration of reservoirs 
(primary resistance), or through selection of resistant parasites as of 
exposure to sublethal drug concentrations (secondary resistance). The latter 
mechanism is responsible for the majority of new cases in areas not known 
to be choroquine-resistant(201,202).  
Malaria endemicity in Saudia Arabia is localized to the southern and 
southwestern parts of the country with the highest number of cases reported 
form Jizan and Asir regions(201,203). Saudi Arabia is considered to be in zone 
(Chloroquine sensitive P. falciparum) according to the World Health 
Organization(204). In 1995, almost 19.000 cases of Health, 88% of which 
were caused by P. falciparum, and 74% of the cases were acquired 
locally(205,206,207), most of these are acquired in areas bordering Yemen and of 
the R1 type. Resistance of the parasite plasmodium to chloroquine is now 
well documented at least in East and Central Sudan. Chloroquine resistance 
was initially suggested in 1978(208). However later studies conducted at 
central Sudan (209), and in eastern Sudan confirming the presence of 
resistance(210). More recently studying the phenomenon in children in Wad 
Medani, Sudan confirmed the in-vivo occurrence at R1-R111 levels of 
resistance(211). P. falciparum resistance is increasing worldwide especially in 
Africa, South East Asia and recently Yemen(212). P. vivax resistance has just 
started to attract attention but to a lesser extent(213,214,215).  
On the basis of chloroquine resistance:  
Since the first chloroquine-resistant P. falciparum strains emerged 
simultaneously and independently in Southeast Asia and Latin America 40 
years ago, the mechanistic basis of this phenotype has been the cause of 
great controversies. A number of contradictory models have been proposed 
to explain the central feature of the chloroquine-resistant phenotype, that is: 
resistant parasites accumulate chloroquine approximately 1000-fold less than 
do sensitive parasites. This suggests that a reduction in intracellular 
chloroquine concentration, below levels necessary to inhibit haem 
metabolism or haem-dependant enzyme activities, is responsible for 
resistance. This reduction can be explained by a number of contradictory 
models:  
• The differences in chloroquine-resistant P. falciparum  strains have an 
elevated pH in their acidic lysosomes that would reduce a acidotropic 
accumulation of the diprotic weak base chloroquine(216).  
• Changes in ion exchange processes altered partition of chloroquine(217), 
and may affect the transmembrane electrical potential such that less 
chloroquine able to diffuse across the membranes in resistant 
parasites(218).   
•  Mutation of carrier-mediated chloroquine transport mechanism                  
(P-glycoprotein (pghl) mediated efflux transport system) that would affect 
either chloroquine uptake, or efflux, or both(219).  
•  Resistance to chloroquine occurs via an active energy-dependent process of 
efflux of chloroquine from Plasmodium falciparum parasite cells(6).  
•  Mutation of a haem-binding protein of the chloroquine-resistant parasite 
strains which control the access of chloroquine to haem(220). 
•  Genetic data have recently been presented that implicate transport 
phenomena of pghl crucial components of the chloroquine-resistant 
phenotype. Two multidrug-resistant- like genes, pfmdr l and pfmdr 2, 
were identified in P. falciparum, and defined point mutation in pfmdr l 
were implicated in chloroqine resistance(221).  
A genetic cross between a chloroquine resistant and a sensitive      P. 
falciparum clone identified another possible genetic determinant. In this 
cross, a 400 Kb region of the P. falciprum chromosome 7 were found to 
segregate with the chloroquine-resistant phenotype. Analysis of this locus 
identified a candidate gene called cg2(222).  
Re-examination of the same locus has now identified a second 
candidate gene, termed pfcrt encoding a putative transporter of hitherto 
unknown location and function(223).  
In vivo the response on  chloroquine treatment is graded based on the 
response to standard doses and duration of chloroquine therapy: (i) S 
(susceptible) refers to cure; (ii) RI (low-level resistance) refers to clearance 
of the parasitemia followed by recrudescence within 28 days; (iii) RII 
(intermediate-level resistance) refers to a clearance, but incomplete 
clearance of the parasitemia; and  (iv) RIII (high-level resistance) refers to 
an increase or no detectable decrease in the degree of parasitemia(201). The 
only reliable definition of “resistance” in malaria parasites is based on 
clinical and parasitological response in symptomatic patients(224). 
 
  
 JUSTIFICATIONS AND OBJECTIVES 
 
JUSTIFICATIONS: 
1. Yemen is a malarious area; malaria represents a public health problem in 
the Republic of Yemen.  The estimated malaria cases occurring annually 
in Yemen are 1.800.00 and the reported fatality rate is of 1% of the 
affected children mostly among Children < 5 years. They are considered 
number one target of malaria infection (15,125,126). 
2. Certain children presented with severe malaria especially those <5 years 
old, while adults came with simple malaria infection. 
3.  In spite of effective malaria control large scale programs and proper 
management in Yemen, malaria is still widely spread. 
4.  Severe malaria is the most important risk factor. It is reemerging as the 
first infectious killer and it is the Number 1 priority tropical disease of the 
World Health Organization.  
5.  Identifying associated factors in children with malaria such as poverty, 
illiteracy, lifestyle, vaccination, malnutrition and others can give valuable 
information for prevention of malaria. 
6.  Environmental (season, climate, rainfall and vector) and human factors 
(agricultural, migration activity, and socioeconomic) may affect malaria 
spreading and cause difficulties of malaria control.  
7. No similar studies were done in Hajjah Province.  
 
 
OBJECTIVES: 
1. To study the presentation of malaria in children, in Hajjah Governorate. 
2. To determine the risk factors leading to malaria among these children. 
3. To document the response to treatment and final outcome of patients 
admitted to the paediatric word. 
4. Determination of haptoglobin phenotypes among these children with 
malaria. 
 
 
 
 
 
 
  
 
 
2. PATIENTS AND METHODS 
 
2.1. Nature of the study: 
This is descriptive cross-sectional hospital-based study. 
2.2. Study area (Place of the study): 
The study was conducted in Hajjah Province at the Saudi Hospital, 
which is built in the center of Hajjah city. Hajjah city is located at the north 
of Yemen, at 150 kilometers from the capital of Yemen Sana'a. Hajjah city 
is about 1800 meters above the red sea level.  
Hajjah is an agricultured area characterized by its seasonal raining 
and valleys (wadi) which run from Sada'a town at the north through many 
small district areas and ended at the Red Sea. One of the these famous 
valleys is "Wadi More" along which poor people are living. The study 
included children from urban and rural areas.  
2.3. Duration of the study: 
The duration was three years, of which 12-18 months were used for 
the survey to collect data and information. 
2.4. Study population:  
2.4.1. Study group: 
The study population included children in the age group birth-12 years 
in whom diagnosis of malaria had been confirmed by positive blood smear. 
A group of age and sex matched children who presented to the hospital for 
causes other than malaria was included as a control even though they are not 
healthy control . 
2.4.2. Sample size:  
The sample size was calculated according to the equation below: 
 
N =          Z2 × Pq 
                                    d2e 
Where: 
N = Sample size. 
z = Statistical certainty = (1.96 at 95% level of confidence).   
p = Prevalence. 
q = Probability of failure at 95%. 
d = designed margin of error (0.05). 
Accordingly, the sample size was calculated to be 563 children. 
2.5. Inclusion criteria: 
The children enrolled in the study were those: 
2.5.1. Aged birth-12 years old. 
2.5.2. Complaining of fever, rigors, sweating, cough, or any other 
symptoms suggestive of mild, severe or complicated malaria. 
 
 
 
2.5.3. Positive malaria blood films should be repeated three times . 
Children were selected for the study after their routine assessment by a 
medical staff; the study did not interfere with routine hospital practice. 
2.6. Exclusion criteria: 
Children who were not enrolled in the study  were those: 
2.6.1. Age above 12 years 
2.6.2. Long standing debilitating disorders such as chronic liver 
disease, chronic renal disease, congenital malformation or malignancy. 
2.6.3. Negative malaria blood films. 
2.7. Study design: 
 2.7.1. Questionnaire: A sheet questionnaire was designed in which 
 information obtained from each child were entered. 
2.7.2. Consent: verbal consent was taken from the medical doctors of 
the hospitals, from the parents and the guardians of the children 
included in the study.  
2.7.3. History and examination: The history obtained from each 
patient included information about individual data as age, family 
income, duration of symptoms, pattern of fever and all symptoms 
related to malaria were obtained and recorded. Detailed examination 
was performed with emphasis on general condition of the patients, 
respiratory system, cardiovascular system, abdomen, central nervous 
system for the signs of cerebral malaria and possible signs of 
complications were obtained. Both Blantyre coma scale and Glasgow 
coma scale where used for assessment level of consciousness. 
2.7.4. Investigations: 
 A blood sample 3 – 5 cc was obtained for the following : 
 2.7.4.1.  Investigations to be done for all the patients: 
• Complete blood picture: Included hemoglobin, red blood cells, white 
blood count, hematocrite and platelets in addition to erythrocyte 
sedimentation rate. Hemoglobin concentration was measured by 
spectrophotometry. 
• Blood group and Rhesus factor. 
• Fasting blood glucose level. 
• Liver functions and renal functions tests: aminotransferase, total 
bilirubin, direct bilirubin, creatinine and blood urea nitrogen. 
• Serum electrolytes as: sodium, potassium and chlorides. 
• Haptoglobin phenotypes were performed by electrophoresis of sera on 
polyacrylamide gel. 
• Arterial blood gases. 
• Complete urine analysis. 
• Thin and thick blood films stained with Giemsa stain for detection and 
characterization of malaria parasites. 
• Determination of the parasite density (Parastaemia). 
• Blood films: 
Thin and thick blood films made on a clean 25mm x 75 mm grease 
free glass slides. The patient's finger cleaned with alcohol, allowed to 
dry and then the side of the fingertip pricked with a sharp sterile 
lancet. Two drops of blood were placed at one end of the slide. 
- Thin films: The thin film was made immediately by placing the smooth 
leading edge of the second (spreader) slide in the central drop blood, at an 
angle of 44 degrees while holding the edges of the slide. The blood 
smeared by pushing the spreader rapidly forward at the same angle. 
- Thick films: The other drop of blood was mixed thoroughly by motion 
with the corner of the second slide (spreader slide), then the films allowed 
to dry completely and protected from any liquids. The films were stained 
using Giemsa stain which consisted of Giemsa powder (Azyure B type) 
3.5 gm; pure glycerol 250 ml and methyl alcohol 250ml. 
- Technique of staining the thin films: The thin films were fixed for 30 
seconds with 1-2 drops of methanol and allowed to dry. The staining 
solution was freshly prepared by mixing 5 ml of stock solution with 100 
ml of buffered water. The slides were transferred to the diluted staining 
solution and left to stain for 20-30 minutes. The slides were flushed with 
tap water and were put upright to dry. 
- Technique of staining the thick films: The thick films were thoroughly 
dried. The staining solution was freshly prepared by mixing 5 mls of 
Giemsa solution with 100 ml distilled water adjusted to neutral or pH 7.2 
using phosphate buffer. The slides were transferred to a jar containing the 
diluted staining solution for 30 minutes and then gently flushed with 
water for 10-15 seconds and allowed to dry. 
- Determination of the parasitaemia : The percentage of parasitaeamia was 
calculated as the total count of infected red blood corpuscles (RBCs) per 
100 counted in Giemsa stain thin blood film. 
% Parasitaemia = number of infected RBCs X 100/total number of the RBCs  
The parasite load was estimated to range from mild to severe on a scale of 1-
4, corresponding approximately to < 5%, 5% -  10%, 10% -20 and >20% 
respectively. 
2.7.4.2.  Investigations to be done when required: 
• Cerebro-spinal fluid examination. 
• X-rays, abdominal ultrasound, bone marrow aspiration and splenic 
aspiration. 
 
 
2.7.5. Confirmed diagnosis: 
♦ Simple (uncomplicated) Malaria. 
♦ Severe Malaria. 
♦ Cerebral Malaria. 
2.7.6. Management : symptomatic, supportive and curative. 
2.7.7. Outcome : was evaluated in regards to full recovery, recovery with 
complications or death. 
2.8. Data analysis:  
The collected data was carefully screened to discard those with 
uncertainty or doubt about its competency. Data was tabulated and 
statistically analyzed by the aid of (SPSS) program version 10.0. For 
parametric (numerical) data, t-test and F-Test were used. For non- 
parametric data, Chi-Square (X2) and Fisher exact tests were used. Pearson 
Correlation was used for correlation between parametric data.           P-value 
of less than 0.05 was used as a significance level.  
2.9. Participants (or research team): 
• The author. 
• Paediatric doctors on call. 
• Laboratory technician. 
• Nurse staff. 
2.10. Difficulties encountered : 
• Transportation: patients who live in the village failing to afford 
means of transportation to come to the hospital. 
• Ignorance: some patients came with relatives, neighbor and 
friends, not the parents from whom proper history was difficult to 
obtain. 
• Poverty: parents have no money to bring their children to the 
hospital and to buy medications. 
• Fear of hospitalization by the relatives. 
• Failure to take oral medication due to vomiting.  
3. RESULTS 
3.1. Characteristic of the study group: 
3.1.1. Gender and age distribution: 
The total number of patients was 563. Males constituted (60.7%) of 
the children under study, whereas (39.3%) were females. As regard to age 
distribution, the table showed that (58.1%), (27.9%) and (14.0%) were in the 
age group of < 4 years, 5-8  and 9-12 years respectively. 
The mean age was 4.37± 3.22 years (Figures 1 & 2). 
3.1.2. Residence: 
The patients were from Hajjah Province, (85%) were from the rainy 
Mabian town and its surrounding villages and those living along the valley 
(Wadi More), were the people are exposed to mosquito bites. The remaining 
(15%) were from scattered agricultural and rainy areas surrounding Hajjah 
City. Few cases were from Hajjah city. 
3.2. History of the present attack (presenting symptoms): 
3.2.1. Main complaints: 
The duration of the complaints was less than one week in (76.0%) 
whereas, it was more than one week in about (24.0%). Fever was the main 
presenting symptom in (98.9%) of children and it was reported to be high 
grade in (99.8%) of them. Fever was continuous in (99.1%) and it was 
associated by rigors, headache and sweating in (33.75%), (26.8%) and  
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      children according to their age (n = 563)
  
 
 
 
Fig. 2: Frequency distribution of the studied            
    children according to their sex (n = 563)
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(13.68%) respectively .As regarding the duration of fever and the time 
lapsed before seeking medical advice, it was shown that (87.25%) of the 
children were contacting hospital in the first week, while the remaining 
(12.25%) took more than one week before seeking medical advice.         
3.2.2. Other complaints:  
Pallor was found in 306 patients (54.35%), cough in 271 patients 
(48.13%), anorexia in 227 patients (40.32%), dyspnea in 210 patients 
(37.30%), abdominal distension in 151 patients (26.85%), abdominal pain in 
115 patients (20.43%) and abdominal swelling in 75 patients (13.32%).        
Jaundice was detected in 42 patients (7.5%), epistaxis, in 3 patients (0.5%), 
generalized body-ache in 118 patients (20.96%), arthralgia in 107 patients 
(19.0%). Convulsions were detected in 62 patients (11.0%) and backache in 
58 patients (10.3%). Loss of consciousness in 53 patients (9.41%), 
drowsiness in 13 patients (2.31%), abnormal gait in 7 patients (1.24%) and 
hallucination in 6 patients (1.07%) as shown in (Table 1).  
3.3. Past Medical history:  
       The Past history of malaria was reported in 393 patients (69.8%), 
whereas cerebral malaria was reported in only five patients (0.89%). 
Evidence of malnutrition was detected in 372 patients (66.07), febrile 
convulsions in 29 patients (5.15%) and infectious diseases in 32 patients 
(5.68%).  The use of Anticonvulsants were reported in 5 patients (0.89%)  
Table 1: Frequency distribution of the studied children according to 
their presenting symptoms (n=563) 
Percentage  % Number of cases Symptoms 
98.93 557 Fever  
66.61 375 Vomiting  
54.71 308 Diarrhea 
54.35 306 Pallor 
48.13 271 Cough  
40.32 227 Anorexia 
37.30 210 Dyspnoea  
33.75 190 Rigors 
26.85 151 Abdominal distension 
26.82 151 Headache 
20.96 118 Generalized body ache 
20.43 115 Abdominal Pain 
19.0 107 Arthralgia 
13.68 77 Sweating 
13.32 75 Abdominal swelling 
11.0 62 Convulsions  
10.3 58 Backache 
9.41 53 Loss of consciousness 
7.5 42 Jaundice 
2.31 13 Drowsiness 
1.24 7 Abnormal gait 
1.07 6 Hallucination 
0.53 3 Neck rigidity 
0.5 3 Epistaxis  
while past history of prior anti-malarial medications in 151 patients 
(26.85%)  as shown in (Table 2) .There was no significant correlation 
between socioeconomic level and past history of malaria (P < 0.13) as 
shown in (Table 3).  
  3.4. Family history: 
         It was noticed that about half of the families (48.67%) had 3-5 siblings, 
whereas families with <3 siblings constituted 220 (39.08%), and families 
>5siblings represented 69 (12.26%) as shown in  (Table 4). 
 
 
 
 
 
 
  
 
 
 
 
 
Table (2):  Frequency distribution of the studied children according to 
their past history (n=563). 
Occurrence History Variable 
Past history of Frequency % 
Malaria 393 69.8 
Malnutrition 372 66.07 
Prior antimalarial drugs  151 26.85 
Infectious diseases 32 5.68 
Febrile convulsions 29 5.15 
Cerebral malaria 5 0.89 
Anticonvulsants 5 0.89 
 
 
  
 
 
 
 
 
 
Table 3:  Relationship between socioeconomic level of the studied 
children and past history of malaria (n=563). 
Social Class 
Past history of malaria 
Poor Moderate High 
No 146 (29.3%) 16 (32.7%) 8 (53.3%) 
Yes 353 (70.7%) 33 (67.3%) 7 (46.7%) 
X2 = 4.16         
 P = 0.13 
 
 
 
Table (4):  Frequency distribution of the studied children according to 
their family history. 
Parameter Frequency % 
Number of siblings:   
- < 3 220 39.08 
- 3-5 274 48.67 
- > 5 69 12.26 
Mean ± SD    3.38 ± 2.1 
Malaria within family (past / present) 541 96.09 
 
3.5. Socioeconomic history: 
The socioeconomic level and living conditions of the studied 
children showed that (86.75%) of fathers and (100.0%) of mothers of 
children were illiterate. All mothers were housewives, whereas, (15.0%) of 
the fathers were employees or having professional jobs. Two fifth of the 
fathers were non-skilled labourers or jobless, while skilled labourer (44.1%) 
of the fathers. The table shows that (88.6%) of the studied children belong to 
low socioeconomic families, and (77%) of them were living in poor houses 
(Table 5).  
There is no statistical significant differences concerning time lapsing 
from fever till going to hospital in relation to child social class (P=0.47; X2 = 
1.51), child sex (P=0.98; X2 = 0.0) or child age (P=0.43;  X2 = 1.69).  
3.6. State of vaccination: 
Most of the patients (75.55%) were vaccinated up to date, (14.5%) 
had incomplete vaccination, while (10%) were not vaccinated.  
3.7. Clinical examination: 
3.7.1. General examination:  
The mean temperature of the studied children with malaria was 38.76 
± 0.96. It was mild grade (37.5° - 38.4°C) in 149 patients (26.5%),  
high grade (38.5° - >40°C) in 351 patients (62.3%) and up to 37.4   
Table (5):  Frequency distribution of the studied children according to 
their socioeconomic level and living conditions. 
Parameter No. % 
Father's education (n=551*): 
Parameter No. % 
- Illiterate/up to 1ry 478 86.75 Water supply: 
 - Up to 2ry 40 7.26 - Inside pipe 49 8.70 
 - University + 33 5.99 - Outside pipe 36 6.39 
Father's  occupation (n=551*): 
 
- Well 163 28.95
- Workless 63 11.43 - Turaa 315 55.95
- Non skilled labour 162 29.40  
- Skilled labour 243 44.10 Type of latrines: 
- Employee / others  83 15.06 - Nil 366 65.0 
Maternal  education (n=553*): - Pit 151 26.82
- Illiterate/up to 1ry 553 100.0 - Siphone 46 8.17 
Maternal occupation (n=553*):  
- House wife 553 100.0 Type of housing: 
Socioeconomic level (n=563): - Satisfactory 7 1.24 
- Low 499 88.63 - Average 122 21.67
- Moderate  49 8.70 - Poor 434 77.09
- High 15 2.66  
* 12 of the fathers and 10 of the mothers were dead. 
Centigrade degrees in 63 patients (11.2%).   
        Pallor was recorded in 497 patients (88.3%). Jaundice was noted in 71 
patients (12.6%), mild jaundice involved 49 patients (8.7%) and moderate to 
deep jaundice was detected in 22 patients (3.9%).  Dehydration (with 
varying degrees) was observed in 224 patients (39.8%), 179 patients (31.8%) 
had mild dehydration, 23 patients (4.1%) had moderate dehydration while 22 
patients (3.9%) had severe dehydration. Malnutrition (with varying degrees) 
was noted in 457 patients (81.2%), out of whom 271 patients (48.1%) had 
mild malnutrition, 137 patients (24.3%) had moderate malnutrition and 49 
patients (8.7%) had severe malnutrition . 
As regard results of vital signs, The mean respiratory rate was 35.94 
± 9.64, pulse rate 131.36 ± 11.71 and systolic blood pressure 90.2 ± 9.61 
while hypotension complicated 61 patients (22.1%) as shown in  (Table 6). 
3.7.2. Head, neck and upper limbs: 
Seven patients (1.24%) had microcephaly ,53 patients (9.4%) had 
rickets and 3 patients (0.53%) had neck rigidity. 
 3.7.3. Cardiovascular system (CVS):  
A minority of children (2.1%) were diagnosed as having cardiac 
signs in the form of haemic murmur.  
Table (6):  Frequency distribution of the studied children according to 
their general clinical signs (n=563). 
Sign No. % Sign No. % 
Pallor 497 88.3 Temperature: 
Jaundice: 71 12.6     -up to 37.4 63 11.2 
   - Mild 49 8.7     -37.5 / 38.4 149 26.5 
   - Moderate/deep 22 3.9     -38.5 / 40 304 54.0 
Dehydration: 224 39.8     ->40 47 8.3 
   -Mild 179 31.8 
 
Mean ± SD 38.76 ± 0.96 
   -Moderate 23 4.1 
   -Severe 22 3.9 Respiratory rate: 
Child weight:     -up to 20 23 4.1 
   - Normal 106 18.8     -21 / 40 422 75.0 
   -Under nutrition: 457 81.2     ->40 118 21.0 
    = Mild  271 48.1 
    = Moderate  137 24.3 
Mean ± SD 35.94 ± 9.64 
    = Severe  49 8.7 Heart rate: 
Systolic blood pressure (n=276):     -up to 100 23 4.1 
    - Normal 215 77.9     -101 / 120 86 15.3 
    - Hypotensive 61 22.1     -121 / 140 409 72.6 
    ->140 45 8.0  
Mean ± SD 90.2 ± 9.61 Mean ± SD 131.36 ± 11.71 
 
 
 
 
 
3.7.4. Respiratory system (RESP.S): 
The main signs found on chest examinations were wheezy chest 
found in 101 patients (17.9% ), crepitations in 79 patients (14.0%) and 
acidotic breathing in 15 patients (2.7%). 
3.7.5. Abdomen:  
Abdominal examination revealed hepatomegaly in 116 patients 
(20.6%), whereas, splenomegaly affected 177 patients (31.6%). 
3.7.6. Central nervous system: 
CNS examination (cranial nerve palsy, ptosis, nystagmus, squint, 
pupil abnormalities, abnormal response to light and abnormal corneal reflex) 
were less frequent and ranging from (2.0% - 4.4%). 
Abnormal position was noted in 81 patients (14.4%), 35 patients of 
them had decerebrate rigidity (6.2%), decorticated rigidity in one patient 
(0.2%), opisthotonus was noted in 15 patients (2.7%) and neck retraction in 
30 patients (5.3%). 
 Impaired level of consciousness was noted in 42 patients (7.5%), 
speech abnormalities was noted in 37 patients (6.6%), out of them dysphasia 
observed in 24 patients (4.3%), dysarthria noted in 4 patients (0.7%) and 
others noted  in 9 patients (1.6%). 
Pupil abnormalities was observed in 25 patients (4.4%), and absence 
of light response noted in 20 patients (3.6%), squint noted in 15 patients 
(2.7%), absent corneal reflexes was noted in 11 patients (2%) and cranial 
nerve palsy was noted in 12 patients (2.1%). It was noticed that 
abnormalities (except abnormal coordination 33.9% ) of the  upper limbs 
affect a minority of the children not exceeding (7.5% ) for decreased power, 
abnormal reflexes (4.3%), loss of sensation (3.7%) and (3.4%) with 
abnormal tone.   
Coordination abnormalities of the lower limbs were noted in 191 
(33.9%), power was affected in 40 patients (7.1%), clonus noted in 26 
patients (4.6%), reflexes affection noted in 22 patients (3.9%), and loss of 
sensation noted in 22 patients (3.9%).  
3.7.7. Musculo-skeletal system: 
Generalized bodyache was noted in 118 patients (20.96%), arthralgia 
noted in 107 patients (19.0%), backache noted 58 patients (10.3%), 
abnormal gait in 7 patients (1.24%) and neck rigidity in 3 patients (0.53%). 
3.8. Investigations performed:  
3.8.1. Routine investigations: 
• Urine analysis:  
Urine was acidic in all specimens and the mean specific gravity was 
1020 ± 5. It was abnormal in 12 patients (2.3%), and the remaining 518 
(97.7%) patients were within normal ranges (1010 - 1015).  RBCs detected 
higher than normal in 97 patients (18.3%). The remaining 433 patients 
(81.7%) had normal range (up to 5 RBCs). The mean RBCs was 3.21 ± 4.43. 
WBCs count was detected higher than normal in 112 patients (21.1%). The 
remaining patients, 418 patients (78.9%) had a normal range (up to 5 
WBCs). The mean WBCs is 3.46 ± 3.91. Schistosoma hematobium ova was 
detected in 19 patients (3.6%). Crystals were noted in 213 patients (40.2%), 
the remaining 317 patients (59.8%) were normal without crystals. 
Haemoglobinuria was noted in 267 patients (50.4%).  The remaining 263 
patients (49.6%) were normal without haem in the urine.  Tea like coloured 
urine was seen in 13 patients (2.5%) as shown in (Table 7). 
Thirty patients (5.3%) were anuric, 274 patients (48.7%) were 
voiding up to 250 cc, 185 patients (32.9%) were voiding 250 to 500 cc, and 
the remaining 74 patients (13.1%) were voiding more than 500c (Table 8).  
Table 7:   Frequency distribution of the studied children according to 
their results of complete urine analysis (n=530). 
Variable No. % Variable No. % 
Color: WBCs: 
Clear/amber yellow 276 52.1 Within normal 418 78.9 
Dark yellow 241 45.4 Higher than normal 112 21.1 
Tea color 13 2.5 Mean ± SD  3.46 ± 3.91 
Specific gravity: Crystals: 
Normal 518 97.7 No 317 59.8 
Abnormal 12 2.3 + 133 25 
Mean ± SD  1020 ± 5 ++ 66 12.4 
Urine pH: +++ 14 2.6 
Acidic 530 100.0 Hemoglobin urea: 
Alkaline - 0.0 No 267 50.4 
Mean ± SD  5.67 ± 0.67 Yes 263 49.6 
RBCs: Presence of Ova: 
Within normal 433 81.7 Schistosoma: 
Higher than normal 97 18.3 No 511 96.4 
Mean ± SD  3.21 ± 4.43 
 
Yes 19 3.6 
 
  
Table (8):  Frequency distribution of the studied children according to 
their urine output characteristics . 
Character Number % 
Amount in previous 6 hours: 
     - Voiding no urine  (anuric)  30 5.3 
     - Up to 250 cc          274 48.7 
     - > 250-500 cc            185 32.9 
     - > 500 cc            74 13.1 
Total 563 100.0 
Color of urine: 
     - Colorless/amber yellow 276 52.1 
     - Dark yellow 241 45.4 
     - Tea like colored 13 2.5 
Total 533 100.0 
 
 
 
  
 
 
3.8.2. Haematological tests: 
* Complete Blood Count (CBC): 
The heamoglobin concentration was less than 5 g/dl in 348 patients 
(61.8%), 145 patients (25.8%) had heamoglobin concentration between 5 -
10 g/dl and only 70 patients (12.4%) with heamoglobin concentration more 
than 10 g/dl (Table 9). The mean Hb concentration was 6.69 ± 2.6 g/dl.  
RBCs count was diminished in 443 patients (78.7%), hematocrite 
percentage was below normal in 542 patients (96.3%), thrombocytopenia 
noted in 91 patients (16.2%).A low heamoglobin level was more prevalent 
in the youngest age group ( < 4 years ) when compared with the older age 
groups (5 – 8 years & 9 -12 years). This difference was statistically 
significant ( P = 0.05) as shown in (Table 10). The mean  ±SD of other 
parameters of blood picture were as follows: RBCs (2.96 ± 1.27 
millions/cc), hematocrite (19.75 ± 7.96), platelets (201,442 ± 62505 
thousands /cc), WBCs (10502 ± 6978 thousands/cc) and ESR (22.31 ± 
10.1).  
Leucopenia was noted in 303 patients (53.8%). Leucocytosis was 
noted in 29 patients (5.2%). Normal WBCs was noted in 231 patients  
Table 9:  Frequency distribution of the studied children according to 
their haemoglobin concentration ( n= 563 ) 
Hb concentration (g/dl)  No. of patient % 
< 5  348 61.8 
5 -10  145 25.8 
> 10  70  12.4 
Total  563 100.0 
 
 
 
 
Table 10:  Frequency distribution of the studied children according to 
their haemoglobin concentration in relation to age (n 563)  
Hb concentration (g/dl) Age (in years)  
< 5 5 - 12  > 12  
Total  
< 4 233 (71.3%)  71 (21.7%)  23 (7.0%)  327 (100%) 
5 - 8 81  (51.6%)  45 (28.7%)  31 (19.7%)  157 (100%)  
9 - 12  34  (43.0%)  29 (36.7%) 16 (20.3%)  79 (100%)  
Total   348 (61.8%) 145 (25.8%) 70 (12.4%) 563 (100%) 
(41.0%) ESR was elevated in 315 patients (56.0%), as shown in 
(Table 11). 
** Blood groups: 
Blood group O +ve noted in 197 patients (35.0%), A +ve noted in 
191 patients (33.9%), B + ve noted in 88 patients (15.6%), AB +ve noted in 
67 patients (11.9%), O -ve noted in 8 patients (1.4%), A -ve noted in 7 
patients (1.2%), B -ve noted in 4 patients (0.7%) and AB -ve noted in one 
patients (0.2%) as shown in (Fig. 3 ).  
3.8.3. Tests for malaria parasites: 
Plasmodium falciparum was detected in 504 patients (89.5%) of 
malaria infection, whereas, Plasmodium vivax noted in 55 patients (9.8%) 
and mixed  infection  was  found  in four patients (0.7%) as shown in (Fig. 
4).  
3.8.4. Biochemical tests: 
• Blood glucose estimation:   
Hypoglycemia (blood glucose less than 40 mg/dl) was noted in 100 
patients (22.3%), hyperglycaemia (blood glucose more than 110 mg/dl) was 
noted in 28 patients (6.3%). The rest of the patients, 320 (71.4%) had a 
blood glucose level within the normal range (60-110 mg/dl). The mean 
blood glucose level was 75.25 ± 36.16 mg/dl.  
 
Table (11):  Frequency distribution of the studied children according to 
their blood picture analysis ( n=563 ) 
Variable No. % 
RBCs (million/cc): 
Normal 120 21.3 
Diminished 443 78.7 
Mean ± SD 2.96 ± 1.27 million/cc 
Hematocrite: 
Normal 21 3.7 
Below normal 542 96.3 
Mean ± SD 19.75 ± 7.96 
Platelets (thousands/cc): 
Normal 472 83.8 
Below normal 91 16.2 
Mean ± SD 201442 ± 62505  
WBCs (thousands/cc): 
Normal 231 41.0 
Leukopenia 303 53.8 
Leukocytosis 29 5.2 
Mean ± SD 10502 ± 6978  
ESR: 
Normal 248 44.0 
Elevated 315 56.0 
Mean ± SD 22.31 ± 10.1 
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Hypoglycemia was more frequent among age group (< 4 years) 
accounting for (23.9%) with statistical significant differences from the other 
two groups (8.9%), (10.1%) for the age groups (5-8 years) and (9-12 years) 
respectively (P = 0.000) as shown in (Table 12). 
• Blood sodium estimation:   
Hyponatremia was noted in 426 patients (75.7%), hypernatremia 
noted in four patients (0.7%), the remaining 133 patients (23.6%) had 
normal sodium level (Na+ = 135 - 145 mg/dl). The mean serum sodium 
level was found 131.31±5.56.  
• Blood chloride estimation:   
Diminished blood chloride was noted in 38 patients (6.8%). It was 
elevated in 35 patients (6.2%). The rest of the patients 490 (87.0%) had a 
blood chloride level within the normal range (100 - 110 mg). The mean 
blood chloride level was 104.45 + 7.95. 
• Blood potassium estimation:   
Hypokalemia affected 53 patients (9.4%), Hyperkalemia was noted 
in 19 patients (3.4%), the rest of the 491 patients (87.2%) were within the 
normal range (3.5 - 5.5 meq/L). The mean potassium level was found to be 
3.72 ± 0.71. 
 
 Table 12:  Frequency distribution of the studied children according to 
their blood glucose concentration in relation to age in 563 
patients with malaria 
Age group (in years)  Variable  
0 -4 5 - 8 9 -12  
Total  
Hypoglycemia:  
Yes  
No 
 
78 (23.9%) 
249 (76.1%)  
 
14 (8.9%)  
143 (91.1%)  
 
8 (10.1%) 
71 (89.9%)  
 
100 (14.3%) 
463 (85.7%) 
Total  327 (58%) 157 (27.9%) 79 (14%) 563 (100%) 
 
X2 = 19.87     &     P = 0.000 
 
Liver function tests estimation:   
- Aminotransferase  (AST, ALT): blood ALT was elevated in 561 
patients (99.6%), and was within the normal range (20 - 65 meq/L) in 
two patients (0.4%). The mean blood ALT was 108.29 ± 57.49. Blood 
AST was elevated in 303 patients (53.8%), and was within the normal 
range (15 - 40 Meq/L) in 260 patients (46.2%). The mean blood AST 
is 77.01 ± 38.57. 
-Bilirubin: blood TBIL (normal <1.3 mg/dl) was elevated in all 
patients (100%), the mean blood TBIL is 9.58 ± 4.87. Blood DBIL 
(normal value < 0.3 mg/dl) was elevated in 505 patients (89.7%), the 
rest of the 58 patients (10.3%) were within the normal range. The 
mean blood DBIL was 1.29 ± 2.2.  
• Blood lipid estimation:   
Blood lipids were tested in 188 patients. Blood cholesterol was 
elevated in 66 patients (35.1%), the rest of the  122 patients (64.9%) were 
within the normal range (< 240 mg/dl). The mean blood cholesterol was 
175.26 ± 84.7. Blood triglyceride (30-200 mg/dl) was elevated in 188 
patients (100%). The mean blood triglyceride was 396.49 ± 114.94. 
• Blood creatinine and BUN estimation:   
Blood creatinine was elevated in 390 patients (69.3%), the rest of the 
173 patients (30.7%) were within the normal range (< 0.6 - 1.3 meq/dl). The 
mean blood creatinine was 0.95 ± 0.43. Blood urea nitrogen elevated in 129 
patients (22.9%), and the rest of 434 patients (77.1%) were within the 
normal range (7-20 mg/dl). The mean blood urea nitrogen was 11.43 ± 3.17.  
The arterial blood gases showed that the most commonly affected was 
plasma bicarbonate (HCO3) which affected all the patients (100%), 
abnormally  base excess was noted in 477 patients (84.7%). Percentages of 
children with abnormalities in other parameters were 115 patients (20.4%) 
and 90 patients (16.0%) for PO2, O2 saturation respectively. The blood pH 
was noted acidic in 79 patients (14%), more alkaline in 13 patients (2.3%) 
and normal in 471 (83.7%). The least affected item was PCO2 which was 
noted in 24 patients (4.3%).  
 
 
 
 
 
 
 
  
3.8.5. Special tests: 
3.8.5.1. Habtoglobin phenotype: 
Among 563 patients in our study the haptoglobin phenotypes 
distribution showed that haptoglobin 1-1 was noted in 271 patients (48.1%), 
followed by type 2-1 noted in 122 patients (21.7%) and lastly type 2-2 
noted in 99 patients (17.6%). Hypo/ Ahaptoglobinemia (HpO) was found 
among 71 patients (12.6%) as shown in (Figure 5). 
As regard the haptoglobin phenotypes distribution among 51 
patients with cerebral malaria, type 1-1 was noted in 23 patients (45.2%), 
type 2-1 noted in 10 patients (19.6%), and type 2-2 noted in 9 patients 
(17.6%). Ahaptoglobinaemia was noted in 9 patients (17.6%). In 
comparison of cerebral malaria patients with uncomplicated malaria 
patients (n= 512), the latter showed that Hp 1-1 was noted in 248 patients 
(48.4%), Hp 2-1 noted in 112 patients (21.9%) and Hp 2-2 noted in 90 
patients (17.6%). Ahaptoglobinaemia was noted in 62 patients (12.1%) as 
shown in (Table 13). 
The haptoglobin phenotypes did not show significant differences 
between patients with non cerebral malaria (n = 512) and children with 
cerebral malaria (P = 0.72). As regard the haptoglobin phenotypes  
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Fig. 5: The percentage of haptoglobin phenotype
             among the studied children (n = 563)
distribution among the healthy controls (n = 100). Hp (1-1) was noted in 9 
controls (9%), Hp (2-1) noted in 37 controls (37%), and Hp (2-2) was noted 
in 15 controls (15%). Hypohaptoglobinaemia was noted in 39 healthy 
controls (39%) as shown in (Table 13).  
The haptoglobin phenotype patterns in malaria patients and controls 
differed significantly (P <0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 13: Frequency distribution of the studied children according to 
their haptoglobin phenotypes (n=563).   
Haptoglobin phenotypes  Group  
1 – 1 2 - 1 2-2  HPO 
Total
Malaria:  
- Uncomplicated 
- Cerebral   
 
248 (48.4%) 
23 (45.2%) 
 
112 (21.9%) 
10 (19.6%) 
 
90 (17.6%) 
9 (17.6%) 
 
62 (12.1%) 
9 (17.6%)  
 
512 
51 
Total 271 (46.8%) 122 (20.8%) 99 (17.6%) 71 (14.9%) 563 
Control  09 (9%)  37 (37%)  15 (15%)  39 (39%) 100 
  
Cerebral and uncomplicated malaria : P = 0.72, X2 = 1.35.  
Controls and uncomplicated malaria : P = 0.001, X2 = 75.09.  
 
 
 
 
 
 
  
 
 
3.8.5.2. Parasitaemia:  
Parasitaemia of less than 5% was noted in 354 patients (62.9%), 5% 
- 10% in 168 patients (29.8%) and >10% parasitemia was noted in 41 
patients (7.3%) as shown in (Fig. 6). The mean parasitemia level was found 
4.78±5.1. No statistical significant between the parasitemia level and the 
age group ( p = 0.249) as shown in (Table 14). 
• Correlation of Parasitaemia:  
* No statistical significant differences were noted between the 
parasitaemia level and the age group (P > 0.05) as shown in (Table 14) . 
** Parasitaemia level < 5% was noted more in poor social class (318 
patients, 63.7%), than parasitaemia 5% - 10% (146 patients 29.3%) and 
parasitaemia > 10% (35 patients 7.0%). The same are with moderate and the 
high social classes at which parasitemia level <5% was more than others 
parasitaemia levels. However, no statistical significant differences between 
the three socioeconomic classes neither for parasitaemia order  (P = 0.57) 
nor for its mean level (P = 0.52), as shown in (Table 15). 
*** There was positive correlation between the level of parasitemia and 
total bilirubin level (P=0.02) and direct bilirubin level (P=0.00). There was 
negative correlation between the level of the parasitemia and hemoglobin & 
platelets levels (P=0.03 & 0.001 respectively). On the other  
 
hand there was no correlation between parasitemia level and either 
temperature, SGPT, SGOT or creatinine, P>0.05,  (Table 16).  
**** There were no statistical significant differences between 
parasitaemia level and age, sex and time lapsed from onset of fever till going 
to the hospital (P > 0.05). 
 
 
  
 
 
 
 
 
 
Fig. 6: Frequency distribution of the studied 
           children according to their parasitemia
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 Table 14:  The relation of parasitemia to age groups in 563 patients with 
malaria 
Age groups (in years)  Parasitaemia   
0 - 4 5 - 8 9 - 12  
< 5%  212 (64.8%)  98  (62.4%)  44   (55.7%)  
5 - 10 %  97  (29.7%)  44   (28.0%)  27   (34.2%)  
> 10 % 18   (5.5%)  15   (9.6%)  08   (10.1%)  
Total   327 (58%)     157 (27.9%)      79 (14%) 
 
 X2 = 4.94         
P = 0.249 
 
 
 
 
 
 
 
 
  
Table 15: Relationship between socioeconomic level of the studied 
children and parasitemia level of present infection (n=563). 
Social Class Significance 
Parameter 
Poor Moderate High χ2 P 
Parasitemia: 
< 5% 318 (63.7) 29 (59.2) 07 (46.7) 
5-10% 146 (29.3) 15 (30.6) 07 (46.7) 
> 10% 35 (7.0) 05 (10.2) 01 (6.7) 
2.912 0.57 
Mean ± SD 4.69 ± 4.89 5.55 ± 7.15 5.09 ± 3.54
F-test 0.66      
 P 0.52 
 
 
 
 
 
 
 
 
  
 
Table 16: Correlation between level of parasitemia and certain clinical 
and laboratory findings. 
Variable Pearson Correlation P 
Temperature 0.044 0.15 
Hemoglobin  -0.080 0.03 
Platelets -0.134 0.001 
SGPT 0.072 0.09 
SGOT 0.02 0.64 
Total bilirubin 0.087 0.02 
Direct bilirubin 0.16 0.000 
Creatinine 0.017 0.69 
 
 
 
 
 

3.8.6. Others:  
Lumber puncture was performed in 51 patients with cerebral 
malaria. Turbid or bloody CSF was found in 9 patients (17.6%), sugar 
below normal was detected in 23 patients (45.1%), protein and chloride 
were below normal in 34 patients (66.7%) and 10 patients (19.6%) 
respectively. WBCs and RBCs were detected in 48 patients (94.1%) and 49 
patients (96.1%) respectively. The mean RBCs was 18.73 ± 36.35. The 
mean WBCs was 10.04 ± 20.0. The mean Chlorides was 122.92 ± 15.62 
and the mean Sugars and Proteins were 55.54 ± 34.3 & 65.14 ± 44.41 
respectively.  
 
3.9. Treatment: 
3.9.1. Supportive and symptomatic treatment: 
The received treatment during hospital stay was as follows : nearly 
all children (99.8%) received antipyretics and intravenous fluids. (97.9%) 
and (94.5%) of children received intravenous quinine and oral quinine 
respectively. Antibiotics were received by 58.6% of the children. The least 
drugs used were anti-convulsants (9.1%). 
3.9.2. Specific treatment:   
Specific treatment included intravenous quinine and oral quinine; (97.9%) 
and (94.5%) of children received intravenous quinine and oral quinine 
respectively. Antibiotics were prescribed to 330 children (58.6%).  
3.10. Complications and Outcome: 
3.10.1. Complications:  
The percentage distribution of the complications among the studied 
children showed that cerebral malaria affected 51 children (9.1%) out of the 
563 examined children. Hypoglycemia (calculated from 448 patients) and 
thrombocytopenia occurred in 22.3% & 16.2% of the studied children 
respectively. Affection of the urinary system occurred among 69.3% of the 
infected children. The study revealed a death rate of only 1.6% of the 
studied children. 
3.10.2. Outcome:  
Almost all the patients (98.4%) were discharged well. Those who 
had short stay in hospital ( 1 – 3 days ) were 250 patients (45.1%). Only 9 
patients (1.6%) died. The causes of death were ( percentage was 
calculated from 1.6%) : 
• Cerebral malaria, hypoglycemia and respiratory distress in 2 patients 
(22.2%). 
• Cerebral malaria and cardiopulmonary arrest in 3 patients (33.3%). 
• Cerebral malaria, shock and acute renal failure in two patients  
(22.2%). 
• Cerebral malaria, bronchopneumonia and convulsion in 2 patients 
(22.2%).  
3.11. Comparative clinical features of malaria in children: 
3.11.1. Simple and cerebral malaria:  
1. Comparison between children with cerebral malaria and children 
with non-cerebral malaria: 
The comparison between children with cerebral malaria and children 
with non-cerebral malaria according to fever and fever related complaints. 
Duration of fever before coming to hospital and associated headache were 
the only two factors showing significant difference between children with 
cerebral and non-cerebral malaria. The mean duration of fever was 3.6±2.81 
& 2.41±1.36 days for non-cerebral and cerebral malaria respectively 
(P=0.000). Headache was more frequent in cerebral than non-cerebral 
malaria (47.1% & 24.8%) respectively. 
Other factors showed no statistical significant differences between 
children with cerebral and non-cerebral malaria (Table 17). 
 
 
 Table 17:  Comparison between children with cerebral and children 
with non- cerebral malarial infection according to their 
complaints of fever and fever associated symptoms. 
Type of malarial infection 
Non Cerebral Cerebral 
Total Significance
Complaint 
No. % No. % No. % χ2 P 
Fever: 
                  Yes 506 98.8 51 100.0 557 98.9 
                  No 6 1.2 - 0.0 6 1.1 
Total 512 100.0 51 100.0 563 100.0 
Fisher 
Exact 
test 
0.44
Continuity of fever: 
                  Yes 501 99.0 51 100.0 552 99.1 
                  No 5 1.0 - 0.0 5 0.9 
Total 506 100.0 51 100.0 557 100.0 
0.51 0.48 
High grade fever: 
                  Yes 505 99.8 51 100.0 556 99.8 
                  No 1 0.2 - - 1 0.2 
Total 506 100.0 51 100.0 557 100.0 
0.1 0.75 
Rigors: 
                  Yes 175 34.2 15 29.4 190 33.7 
                  No 337 65.8 36 70.6 373 66.3 
Total 512 100.0 51 100.0 563 100.0 
0.47 0.49 
Sweating: 
                  Yes 67 13.1 10 19.6 77 13.7 
                  No 445 86.9 41 80.4 486 86.3 
Total 512 100.0 51 1.67 563 100.0 
 0.20 
The comparison between children with cerebral malaria and children 
with non-cerebral malaria according to their musculo-skeletal complaints is 
illustrated in (Table 18). Neck rigidity was more common among children 
with cerebral malaria (3.90%) than those with non-cerebral  malaria 
(0.20%). The difference was statistically significant (P = 0.02).  
Convulsion, was more common in patients with cerebral malaria (90.20%) 
than patients with non cerebral malaria (3.10%) the difference was 
statistically significant (P= 0.000). 
Loss of consciousness and hallucination were more common in 
patients with cerebral malaria (82.4%, 7.8%) than patients with non-
cerebral malaria (2.10%, 0.40%) respectively. The difference was 
statistically significant (P = 0.000). On the other hand, drowsiness and 
abnormal gait showed no statistical significant differences P>0.05        
(Table 19). Regarding gastro-intestinal complaints, they showed no 
statistical significant difference  (P>0.05) for all items except anorexia. 
Anorexia was much more frequent among children with non-cerebral 
malaria (42.8%) than those with cerebral malaria (15.7%). The difference 
was statistically significant, P=0.000 & OR=4.02 (Table 20). 
The chest and hemolytic dysfunction showed no statistical significant 
differences except pallor (P>0.05). Pallor was detected in 56.3% of children 
with non-cerebral compared to 35.3% among those with cerebral malaria. 
The difference is statistically significant, P=0.004 & OR=2.36 (Table 21).  
  
Table 18:  Comparison between children with cerebral and children    
with non- cerebral malarial infection according to their 
musculo- skeletal complaints. 
Type of malarial infection 
Non Cerebral Cerebral 
Total Significance
Complaint 
No. % No. % No. % χ2 P 
Generalized body ache: 
                    Yes 107 20.9 11 21.6 118 21.0 
                    No 405 79.1 40 78.4 445 79.0 
Total 512 100.0 51 100.0 563 100.0 
0.01 0.911
Backache: 
                    Yes 54 10.5 4 7.8 58 10.3 
                    No       458 89.5 47 92.2 505 89.7 
Total 512 100.0 51 100.0 563 100.0 
0.37 0.55 
Arthralgia: 
                    Yes 95 18.6 12 23.5 107 19.0 
                    No 417 81.4 39 76.5 456 81.0 
Total 512 100.0 51 100.0 563 100.0 
0.75 0.39 
 
Table 19:  Comparison between children with cerebral and children 
with non-cerebral malarial infection according to their 
neurological complaints. 
Type of malarial infection 
Non Cerebral Cerebral 
Total Significance
Complaint 
No. % No. % No. % χ2 P 
Drowsiness: 
                   Yes 10 2.0 3 5.9 13 2.3 
                   No 502 98.0 48 94.1 550 97.7 
Total 512 100.0 51 100.0 563 100.0 
3.17 0.07 
Abnormal gait: 
                   Yes 5 1.0 2 3.9 7 1.2 
                   No 507 99.0 49 96.1 556 98.8 
Total 512 100.0 51 100.0 563 100.0 
Fisher 
Exact 
test 
0.12
5 
 
 
 
 
 
 
Table 20:  Comparison between children with cerebral and children 
with non-cerebral malarial infection according to their 
abdominal and gastrointestinal complaints. 
Type of malarial infection 
Non Cerebral Cerebral 
Total SignificanceComplaint 
No. % No. % No. % χ2 P 
Abdominal pain: 
                   Yes 106 20.7 9 17.6 115 20.4 
                   No 406 79.3 42 82.4 448 79.6 
Total 512 100.0 51 100.0 563 100.0 
0.27 0.61 
Abdominal swelling: 
                   Yes 69 13.5 6 11.8 75 13.3 
                   No 443 86.5 45 88.2 488 86.7 
Total 512 100.0 51 100.0 563 100.0 
0.12 0.73 
Abdominal distension: 
                   Yes 139 27.1 12 23.5 151 26.8 
                   No 373 72.9 39 76.5 412 73.2 
Total 512 100.0 51 100.0 563 100.0 
0.31 0.58 
Vomiting: 
                   Yes 346 67.6 29 56.9 375 66.6 
                   No 166 32.4 22 43.1 188 33.4 2.39 0.12 
Total 512 100.0 51 100.0 563 100.0 OR = 1.58 
Diarrhea: 
                   Yes 284 55.5 24 47.1 308 54.7 
                   No 228 44.5 27 52.9 255 45.3 1.32 0.25 
Total 512 100.0 51 100.0 563 100.0 OR = 1.4 
Anorexia: 
                   Yes 219 42.8 8 15.7 227 40.3 
                   No 293 57.2 43 84.3 336 59.7 14.14 0.000
Total 512 100.0 51 100.0 563 100.0 OR = 4.02 
Jaundice: 
Yes 36 7.0 6 11.8 42 7.5 
No 476 93.0 45 88.2 521 92.5 
1.51 0.22 
Total 512 100.0 51 100.0 563 100.0 OR = 1.76 
 Table 21:  Comparison between children with cerebral and children 
with non-cerebral malarial infection according to their 
complaints related to chest and hemolytic dysfunction. 
Type of malarial infection 
Non Cerebral Cerebral 
Total Significance
Complaint 
No. % No. % No. % χ2 P 
Cough: 
                   Yes 247 48.2 24 47.1 271 48.1 
                   No 265 51.8 27 52.9 292 51.9 
Total 512 100.0 51 100.0 563 100.0 
0.03 0.87 
Dyspnea: 
                   Yes 188 36.7 22 43.1 210 37.3 
                   No 324 63.3 29 56.9 353 62.7 
Total 512 100.0 51 100.0 563 100.0 
0.82 0.37 
Epistaxis: 
                   Yes 3 0.6 - 0.0 3 0.5 
                   No 509 99.4 51 100.0 560 99.5 
Total 512 100.0 51 100.0 563 100.0 Fi
sh
er
 
Te
st
 0.58 
Haematemsis: 
                   Yes - 0.0 - 0.0 - 0.0 
                   No 512 100.0 51 100.0 563 100.0 
Total 512 100.0 51 100.0 563 100.0 
  
Pallor: 
                   Yes 288 56.3 18 35.3 306 54.4 
                   No 224 43.8 33 64.7 257 45.6 
8.21 0.004
Total 512 100.0 51 100.0 563 100.0 OR = 2.36 
 
As regard the housing conditions, there was no statistical 
significant differences between both groups regarding the type of water 
supply (P = 0.32). Inside pipe was noted in (9.2%) and (3.9%) with non-
cerebral and cerebral respectively. Outside pipe was noted in (6.1%) and 
(9.8%) with non-cerebral and cerebral respectively. Wells were noted in 
(29.5%) and (23.5%) with non-cerebral and cerebral respectively. Turaa 
(channel) was noted in (55.2%) and (62.7%) with non-cerebral and cerebral 
respectively ( χ2 = 3.53,  P = 0.32) .  
Latrines were nil in (63.9%) and (76.5%) with non-cerebral and 
cerebral respectively. Pit was found in (27.5%) and (19.6%) with non-
cerebral and cerebral respectively, while Siphone was found in (9.6%) and 
(3.9%) with non-cerebral and cerebral respectively. There was no statistical 
significant differences between both groups as regard the type of Latrines 
(χ2 = 3.46, P = 0.18).   
Poor housing formed the majority of houses of children with 
cerebral malaria and children with non-cerebral malaria. It was more 
(90.2%) in children with cerebral than in children with non-cerebral malaria 
(75.8%).  Average housing was found in (23.0%) and (7.2%) with non-
cerebral and cerebral respectively, and satisfactory housing was found in 
(1.2%) and (2.0%) with non-cerebral and cerebral malaria respectively, the 
difference is statistically significant, (χ2 = 6.43, P = 0.04). 
Parental characteristics and socio-economic level among children 
with cerebral compared to children with non-cerebral malaria demonstrated 
that father occupation was the only parameter showing statistical significant 
difference (0.03). Other parameters showed no significant differences 
(Table 22).   
The comparison between children with cerebral and children with 
non-cerebral malaria infection regarding their general clinical signs, showed 
that pallor and under-nutrition were the two factors showing statistical 
significant differences (more marked among children with non-cerebral 
malaria). Jaundice showed no significant difference. Moreover, dehydration 
showed no significant difference between both groups. However, severe 
dehydration was higher among the group with cerebral malaria, with 
statistically significant difference (P=0.003). Mean respiratory rate and mean 
pulse rate were significantly higher among children with cerebral malaria 
infection (Table 23). 
 
  
 
 
 
Table 22:  Comparison between children with cerebral and children 
with non-cerebral malarial infection according to their 
paternal characteristics and socioeconomic levels. 
Type of malarial infection 
Non Cerebral Cerebral 
Significance 
Parameter 
No. % No. % χ2 P 
Father education: 
  - illiterate up to primary  437 87.2 41 82.0 
  - Up to secondery 34 6.8 6 12.0 
  - University + 30 6.0 3 6.0 
1.85 0.40 
Father occupation: 
  - Not working 54 10.8 9 18.0 
  - Non skilled labourer  156 31.1 6 12.0 
  - Skilled labourer 218 43.5 25 50.0 
  -Employee& professional 73 14.6 10 20.0 
9.06 0.03 
Maternal education: 
  - illiterate up to primary 503 100.0 50 100.0   
Maternal occupation: 
  - House wife 5.3 100.0 50 100.0   
Social class: 
  - Low  455 88.9 44 86.3 
  - moderate 43 8.4 6 11.8 
  - High 14 2.7 1 2.0 
0.74 0.69 
 
 
 
Table 23:  Comparison between children with cerebral (n=51) and 
children with non- cerebral (n=512) malarial infection 
according to their general clinical signs. 
Type of malarial infection 
Non Cerebral Cerebral 
Significance 
Parameter 
No. % No. % χ2 P 
Pallor 466 91.0 31 60.8 40.96 0.000
Jaundice 65 12.7 6 11.8 0.04 0.85 
Mild 36 7.3 2 3.9 
Moderate 29 5.7 4 7.8 
1.07 0.30 
Dehydration 200 39.1 24 47.1 1.24 0.27 
Mild 163 31.8 16 31.4 
Moderate 22 4.3 1 2.0 
Severe 15 2.9 7 13.7 
11.81 0.003
Under nutrition 426 83.2 31 60.8 15.25 0.000
Mild 251 49.0 20 39.2 
Moderate 129 25.2 8 15.7 
Severe 46 9.0 3 5.9 
0.38 0.83 
Vital signs (Mean ± SD): t-test P 
-Temperature 38.76 ± 0.96 38.74 ± 0.96 -0.19 0.85 
-Respiratory rate 35.66 ± 9.75 38.73 ± 8.07 2.17 0.03 
-Pulse rate 130.92 ± 11.66 135.86 ± 11.29 2.9 0.004
-Systolic blood   
 pressure 
90.56 ± 9.29 86.85 ± 11.86 -1.91 0.06 
 
 
The Comparison between children with cerebral and children with 
non-cerebral malarial infection according to their cranial nerves 
abnormalities showed that there were statistical significant differences 
(P=0.000) between children of both groups. There were higher in cerebral 
malaria as regard nystagmus, pubil abnormality and absence of light and 
corneal reflexes.  
No statistical significant differences could be detected for both 
hepatomegally and splenomegally (P>0.05). However, splenomegaly was 
higher among children with cerebral malaria.  
The comparison between children with cerebral and children with 
non-cerebral malaria according to blood picture showed that the mean 
values of all parameters of blood picture (except ESR) were higher in 
children with cerebral malaria. The mean ESR level was higher in children 
with non-cerebral malaria. All these differences were statistically 
significant (P = 0.00) as shown in  (Table 24).  
The comparison between children with cerebral and children with non- 
cerebral malarial infection according to their blood group showed that 
children with blood group O-ve were more affected with cerebral malaria 
followed by children with blood group A-ve. Cerebral malaria affected 
(37.5%) and (28.6%) of children with blood group  O-ve and A-ve 
respectively. However, group O-ve was the only group showing statistical  
Table 24:  Comparison between children with cerebral (n= 51) and 
children with non-cerebral (n=512) malarial infection 
according to their blood picture. 
Type of malarial infection 
Non Cerebral  Cerebral  
Significance 
Parameter          
(Mean ± SD) (Mean ± SD) t-test P 
Hemoglobin (gm/dl) 6.57 ± 2.58 7.90 ± 2.50 3.519 0.000 
Red blood cells  
(in millions) 
2.91 ± 1.27 3.41 ± 1.26 2.66 0.008 
Hematocrite 19.46 ± 7.86 22.67 ± 8.42 2.77 0.006 
Platelets 195118±57766 264922 ± 72733 6.65 0.000 
White blood cells 10224.8 ± 6561 13288 ± 9928 2.16 0.04 
ESR 22.93 ± 9 16.1 ± 12 3.88 0.000 
 
significant difference between children of cerebral and children of non-
cerebral malaria (P = 0.005).    
The comparison between children with cerebral malaria and non-
cerebral malaria according to the parasite species showed that plasmodium 
falciparum infected 96.1% of children with cerebral malaria compared to 
88.9% of children with non-cerebral malaria. The difference, however, was 
statistically insignificant (P=0.1). On the other hand, there was a statistical 
significant difference between children with cerebral malaria and children 
with non-cerebral malaria as regard parasitemia categories (P=0.000) or 
mean parasitemia level (P=0.000). The haptoglobin phenotype did not show 
significant difference between both groups of children P=0.72, as shown in 
(Table 25). 
Blood chemistry analysis in children with cerebral malaria compared 
to children with non-cerebral malaria showed that the mean blood glucose 
level and mean serum chloride did not show statistical significant 
differences, (P>0.05), between children of the two groups. On the other 
hand, mean levels of serum sodium (higher in non-cerebral malaria) and 
serum potassium (higher in cerebral malaria) showed statistical significant 
differences between the two groups of children, (P<0.05) as shown in 
(Table 26). 
 
Table 25:  Comparison between children with cerebral (n=51) and 
children with non- cerebral (n=512) malarial infection 
according to their factors related to parasite infection. 
Type of malarial infection 
Non Cerebral  Cerebral  
Significance 
Parameter 
No. % No. % χ2 P 
Malaria species: 
Plasmodium falciparum 455 88.9 49 96.1 
Plasmodium vivax/mixed 57 11.1 2 3.9 
2.57 0.1 
Parasitemia: 
< 5% 334 65.2 20 39.2 
5%-10% 154 30.1 14 27.5 
> 10% 24 4.7 17 33.3 
57.36 0.000
Mean ± SD 4.2 ± 3.2 10.6 ± 12.1 t=3.74   P= 0.000 
Haptoglobin phenotype: 
Type 1-1 248 48.4 23 45.2 
Type 2-1 112 21.9 10 19.6 
Type 2-2 90 17.6 9 17.6 
Ahaptoglobinemia 62 12.1 9 17.6 
1.35 0.72 
 

Table 26:  Comparison between children with cerebral (n=51) and 
children with non-cerebral (n=512) malarial infection 
according to their blood chemistry analysis. 
Type of malarial infection 
Non Cerebral  Cerebral  
Significance 
Parameter 
Mean ± SD Mean ± SD t P 
Blood glucose* 73.4 ± 31.1 90.3 ± 61.5 1.93 0.06 
Serum sodium 131.5 ± 5.5 129.1 ± 6.0 3.0 0.003 
Serum potassium 3.68 ± 0.69 4.06 ± 0.88 2.96 0.005 
Serum chloride 104.51 ± 8.17 103.94 ± 5.25 0.48 0.63 
* Blood glucose was done for 397 cases of non-cerebral malaria and for all 
cases of cerebral malaria. 
 
 
 
 
 
 
 
 
  
The comparison between children with cerebral malaria and children 
with non-cerebral malaria according to their liver functions, lipid profile and 
renal functions showed that (SGPT) was higher in children with non-cerebral 
malaria than those with cerebral malaria, whereas, the reverse was noticed 
for total bilirubin and direct bilirubin levels. These differences were 
statistically significant (P<0.05). As regards lipid profile, cholesterol level 
was higher among children with non-cerebral malaria, whereas, triglycerides 
were higher among children with cerebral malaria. These differences were 
statistically significant (P<0.05). Renal function tests did not show 
significant difference between children of both groups (P>0.05).   
The comparison between children with cerebral malaria and children 
with non-cerebral malaria according to their arterial blood gases was also 
observed. It was noticed that non of the blood gases (except Pco2) showed 
statistically significant difference (P>0.05). Pco2 was lower in children with 
cerebral malaria compared to those with non-cerebral malaria (P<0.05) as 
shown in (Table 27). 
 
 
  
 
 
Table 27:  Comparison between children with cerebral (n=51) and 
children with non-cerebral (n=512) malarial infection 
according to their arterial blood gases. 
Type of malarial infection 
Non Cerebral  Cerebral  
Significance
Parameter 
Mean ± SD Mean ± SD t-test P 
Pco2 35.3 ± 2.9 27.0 ± 9.2 6.37 0.000
Po2 83.3 ± 5.4 87.6 ± 23.6 1.37 0.18 
Oxygen Saturation 95.1 ± 2.6 94.5 ± 2.6 1.57 0.12 
Blood pH 7.37 ± 0.09 7.36 ± 0.09 0.841 0.40 
Hco3 14.39 ± 2.24 13.55 ± 3.37 1.74 0.09 
Base Excess 4.1 ± 1.79  3.62 ± 1.77 1.85 0.07 
 
 
 
 
  
 
3.11.2. Simple malaria in children and the control group: 
The comparison between children infected with malaria and the 
control group according to their blood picture showed that all parameters of 
blood picture except hematocrite and ESR showed statistical significant 
differences (P<0.05) between both groups. Mean hemoglobin level, mean 
RBCs and mean platelet count were less among children with malaria, 
whereas, the mean WBCs was less among the control group (Table 28).  
The comparison between children infected with malaria and children 
of the control group according to blood chemistry showed that the  mean 
blood glucose level did not differ significantly between both groups 
(P>0.05). On the other hand, the mean serum sodium and chlorides were less 
among children infected with malaria, whereas, mean serum potassium was 
higher among them. These differences were statistically significant (P<0.05) 
as shown in (Table 29).  
The comparison between children infected with malaria and children 
of the control group according to their urine analysis showed that urine pH 
was higher among the control group. However, RBCs, WBCs, 
hemoglobinurea and tea like urine were higher among children with malaria 
infection. All these changes were statistically significant (P<0.05) as shown 
in (Table 30). 
Table 28:  Comparison between children infected with malaria (n=563)  and 
the control group (n=100) according to their blood picture. 
Significance 
Children with malaria Control Group  
Variable 
Mean ± SD Mean ± SD t-test P 
Hemoglobin 6.69 ± 2.6 9.27 ± 2.9 8.98 0.000
RBCs 2.96 ± 1.27 3.89 ± 1.87 6.23 0.000
Hematocrite 19.75 ± 7.96 18.6 ± 9.62 1.29 0.198
Platelets 201442 ± 62505 232245 ± 74337 4.41 0.000
WBCs 10502 ± 6978 7416 ± 3765 4.31 0.000
ESR 22.31 ± 10.1 20.52 ± 7.3 1.69 0.09 
 
 
 
 
 
 
 
 
 
  
Table 29:  Comparison between children infected (n=563) with malaria 
and the control group (n=100) according to their results of 
blood chemistry. 
Significance
Children with malaria Control Group 
Variable 
Mean ± SD Mean ± SD t-test P 
Blood glucose* 75.28 ± 36.16 77.6 ± 21.18 0.55 0.58 
Serum Sodium 131.31 ± 5.56 134.29 ± 3.5 5.18 0.000
Serum Potassium 3.72 ± 0.71 3.52 ± 0.5 2.7 0.007
Serum Chlorides 104.45 ± 7.95 110.9 ± 6.54 7.66 0.000
 
* Number of children with malaria was 448, and control group 78. 
 
 
Table 30: Comparison between children infected with malaria (n=530) 
and children of the control group (n=100) according to their 
urine analysis. 
Significance
Variable 
Children       
with malaria 
Control Group  
t-test P 
* Urine pH 5.67 ± 0.67 6.55 ± 1.2 10.38 0.000
* RBCs 3.21 ± 4.43 2.1 ± 1.3 2.48 0.013
* WBCs 3.46 ± 3.91 2.5 ± 2.1 2.39 0.017
Urine color: χ2 P 
- Clear 276 (52.1%) 78 (78.0%) 
- Dark yellow  241 (45.4%) 22 (22.0%) 
- Tea like urine 13 (2.5%) - (0.0%) 
23.62 0.000
Hemoglobinurea: 
- No 267 (50.4%) 88 (88.0%) 
-Yes 263 (49.6%) 12 (12%) 
48.41 0.000
Schistosoma Ova: 
- No 511 (96.4%) 96 (96.0%) 
Yes 19 (3.6%) 4 (4.0%) 
# 0.509
 
# Fisher Exact test was used. 
* Mean ± SD 
The Comparison between children infected with malaria and the 
control group according to their liver function tests, lipid profile and renal 
function tests showed that all liver function parameters (SGPT, SGOT, total 
bilirubin and direct bilirubin) were markedly elevated among children with 
malaria infection. Similarly, creatinine and blood urea nitrogen were higher 
among children with malaria infection. These differences were statistically 
significant (P<0.05). Also, triglycerides (but not cholesterol) were 
significantly elevated among children with malaria infection (P<0.05) as 
shown in (Table 31).  
The comparison between children infected with malaria and children 
of the control group according to their blood gases analysis showed that 
statistically significant  changes (P<0.05) for all parameters except blood 
pH, between children with malaria infection and children of the control 
group (Table 32). 
The comparison between children infected with malaria and children 
of the control group according to their Haptoglobin phenotype showed that 
statistically significant (P = 0.001) changes between both groups. More 
patients with falciparum malaria had phenotype (1-1) than the healthy 
control (Table 33). 
 
  
Table 31: Comparison between children infected with malaria (n=530) 
and the control group (n=100) according to their liver 
function, lipid profile and renal function tests. 
Significance 
Children with malaria  Control Group  
Variable 
Mean ± SD Mean ± SD t-test P 
SGPT 108.29 ± 57.49  32.2 ± 6.7 13.21 0.000
SGOT 77.01 ± 38.57 20.04 ± 3.6 14.75 0.000
Total bilirubin 9.58 ± 4.87 1.1 ± 0.4 17.39 0.000
Direct bilirubin 1.29 ± 2.2 0.2 ± 0.04 4.95 0.000
Cholesterol* 175.26 ± 84.7 170.3 ± 30.7 0.58 0.56 
Triglycerides* 396.49 ± 114.94 106.9 ± 18.4 25.12 0.000
Creatinine 0.95 ± 0.43 0.7 ± 0.21 5.69 0.000
BUN 13.43 ± 7.17 11.22 ± 4.62 2.97 0.003
*number was 188 for children with malaria 
 
  
 
 
 
Table 32: Comparison between children infected with malaria (n=563) 
and children of the control group (n=100) according to their 
blood gases analysis. 
Significance 
Children with malaria Control Group  
Variable 
Mean ± SD Mean ± SD 
t-test P 
PCo2 34.51 ± 4.55 31.46 ± 3.51 6.37 0.000
PO2 83.47 ± 8.82 86.33 ± 6.16 3.11 0.002
O2 Saturation 95.07 ± 2.59 96.63 ± 2.4 5.6 0.000
Blood pH 7.37 ± 0.1 7.38 ± 0.2 0.77 0.444
HCo3 14.31 ± 2.37 12.12 ± 2.35 8.53 0.000
Base Excess: χ2 P 
- normal 86 (15.3%) 93 (93.0%) 
- abnormal 477 (84.7%) 7 (7.0%) 
260.28 0.000
 
  
 
 
 
 
Table 33: Comparison between children infected with malaria (n=563) 
and children of the control group (n=100) according to their 
Haptoglobin phenotype  
Significance Children with 
malaria  
Control 
Group  Variable 
No % No % χ
2 P 
Haptoglobin phenotype 
Type  1-1 271 48.13 9 9.0 
Type  2-1 122 21.68 37 37.0 
Type  2-2  99 17.58 15 15.0 
Ahaptoglobinemia 71 12.61 39 39.0 
Total 563 100.0 100 100.0 
 75.09     0.001
 
 
4. DISSCUSSION 
 
4.1. Characteristic of the study group: 
4.1.1. Gender and age distribution: 
Of the total 563 children enrolled in the study, there was a high 
prevalence of children in the age group < 4 years. This is explained by the 
fact that children below five years of age are less immune. The mean age 
was 4.37± 3.22 years, with age below 12 years old.  
This goes with  WHO, 1990, Greenwood, 1991 and Imbert et al., 
1997 studies which confirmed that in a highly endemic areas falciparum 
malaria infection causes severe and potentially fatal disease in the first five 
years of age(41,1,38). In the early months of life the manifestations of malaria 
are usually mild, this is because of passive immunity acquired from mothers, 
while with the increases of age, a considerable degree of immunity had been 
developed(41,1). The age distribution also matches with Assimadi et al., and 
other studies and contrary with the study in Antananarivo which reported 
that the majority of malaria infected children were of 5 years and more(86, 225-
229).  
As regard the sex distribution, this study showed that there was high 
male to female preponderance. This may be due the fact that males are more 
exposed to mosquito bites because they play outdoors more than females . 
This matches with other studies(42,230).   
 4.1.2. Residence: 
Most of the affected patients were from Mabian town and 
surrounding villages and those living along wadi-more valley, rather Hajjah 
city itself. This can be explained by the geographical nature of the area, 
whereas, Hajjah city is high above the sea level, while Wadi-more is an 
agricultural area with large irrigation scheme which is favourable for 
mosquito breeding.      
4.2. Patients complaints: 
4.2.1. Main complaints: 
Fever was the main presenting symptom of nearly all the patients and 
it was severe in the majority of patients. This is due to the release of pro-
inflammatory cytokines and other various mediators. This is consistant with 
Nahla study(31, 32,104,226). 
Rigors and sweating, which were a feature of typical malaria in non-
immune children, were encountered in small number of patients, unlike 
other studies in which higher percentages were found(42, 226). This can be 
explained by the fact that most of the patients had repeated attacks of 
malaria or received medication(231).  In our study headche was a common 
symptom, which is consistant with Banzal et al, but differs from what was 
prescribed by other studies(42, 226).   
 
The majority of patients presented with fever and gastrointestinal 
symptoms such as vomiting, diarrhoea and anorexia. Occurance of vomiting 
was consistant with Sowunmi et al study who found that vomiting was the 
most common presenting symptom among children with uncomplicated 
malaria(43). Diarrhoea, in our study, was higher than other studies(226,229). This 
is can be explained by concomitant gastro-enteritis, since it is commoner in 
children in developing countries. 
4.2.2. Other complaints 
Pallor was consistant with Nahla study, but was much less with other 
studies(226, 42). Although platelets count was lower than normal among 91 
patients (16.2%) of the studied children, complaints of bleeding tendency 
(epistaxis and haematemsis) were almost not mentioned. This matches with 
Nahla study of bleeding tendency in which only two patients (1.2%) of the 
children in her study had bleeding tendency(226) . 
Cough and dypsnea were reported in about half and more than one-
third of our patient respectively. This was consistant with Anstry, et al study 
and another study(77,76).  
Convulsions and loss of consciousness were found to affect minority 
of our study. This matches with Banzal, et al study(42). On the other hand, 
higher figures were found in other studies(227,226,232). Oliguria was strikingly 
much higher than reported in another studies(226).   
Some of the mentioned symptoms such as fever, sweating, cough 
and other symptoms of severe malaria were so diverse and not specific for 
malaria. Consequently acute malaria can be considered in the differential 
diagnosis of any febrile illness.  
4.3. Past medical history: 
About three-quarter of the patients had a past history of a previous 
attack of malaria. This indicates the high prevalence of malaria in the 
community. About one quarter of the patients had prior antimalarial drugs, 
mainly oral quinine, within one month of the study.  
4.4. Family history: 
 Ninety-six percentage of the studied children's families had past 
history of malaria. Severe malaria was the leading cause of death. This 
reflects the high prevalence and mortality of malaria among their families 
and the community.  
4.5. Socioeconomic history: 
Malaria is more common among those children with poor housing 
conditions which is explained by poor ventilation and stagnant water that is 
common in most of those houses. However, Luckner et al (1998) in their 
study suggested that, the socioeconomic determinants are not major risk 
factors for severe malaria in African children(52).     
 
4.6. State of vaccination: 
In this study 75.6% of the patients completed their vaccination up to 
date according to the National Immunization schedule, which is much less 
than the objectives of the health agencies and organizations. This low 
vaccination coverage may be explained by the finding that (88.6%) of the 
studied children belong to families of low socioeconomic level while 
(86.8%) and (100.0%) of their fathers and mothers were illiterate 
respectively. 
4.7. Clinical examination: 
4.7.1. General examination: 
Almost all patients were either ill or very ill. This was an expected 
finding since malaria, being a multisystem disease, has adverse local and 
systemic effects(233).   
In this study all patients were febrile with temperature range (37.5°C 
- > 40°C). This is consistent with the WHO statement that most but not all 
children with malaria were febrile with rectal temperature ranging from 
36°C - 40°C or higher(234). Most of our  patients had high grade temperature, 
a fact which was much more than what was found in the study reported by 
Tochokoteu et al in Cameron(225).   
 
Pallor was noted in most of our patients, which was most probably 
because of the haemolysis. Tumor necrosis factor alpha (TNF-α) and 
interleukin (IL-10) were significantly elevated in children with severe 
malaria anaemia(105,109,36,31). This is not consistent with others studies which 
were much less or more(226,42). Severe anaemia was the predominant 
complication in areas of extremely high endemicity where people were 
bitten by hundreds of infected mosquites per year(53). Jaundice was 
encountered in about (30%) of patients with malaria(40,41). In this study it was 
seen in (12.6%) of the patients, (3.9%) of them were with deep jaundice and 
this is probably was due to intravascular hemolysis and the severity of the 
disease. Dehydration was common in children with severe malaria(235). In 
this study it was seen in (39.8%) of the patients and most of them were of 
mild degree dehydration.   Malnutrition was detected in four-fifth (81.2%) of 
the patients. However, recurrent malaria may lead to malnutrition.  
4.7.2. Head, neck and upper limbs: 
Rickets is common in the study area because most of the children are 
not exposed to sun light and from poor families. The findings of 53 patients 
was an underestimation.  
4.7.3. Cardiovascular system (CVS):  
Ventricular septal defect (VSD) was discovered accidentally in four 
patients. Haemic murmur was heard in 7 patients. 
4.7.4. Respiratory system (RESP.S.): 
Pulmonary manifestations are frequently observed in children with 
malaria(75,76,77).Respiratory distress is a predictor sign of death(80,53,29). 
Bronchiolitis was noted in (17.9%) of the patients. This was consistant with 
Rajput study(76). On the other hand Bronchopneumonia was noted in (14.0%) 
of our patients, where it was detected in only (4%) patients of Rajput 
study(76).  
4.7.5. Abdomen: 
Hepatosplenomegaly was recorded in (52.2%) of the patients. On the 
other hand Molynex et al recorded hepatosplenomegaly in (42%) of the 
patients(60).   
 4.7.6. Central nervous system: 
Forty-two (7.5%) patients had some degree of impairment of 
consciousness. Absent corneal reflex was noted in 11 patients (2.0%), 
decerebrated rigidity was recorded in 35 patients (6.2%), decorticated 
rigidity recorded in one patient (0.2%).  It was noticed that abnormalities 
(except coordination) of the upper and lower limbs affected only a minority 
of children not exceeding (7.5%) for power. Limbs coordination affected 
(33.9%), others included (5.2%) for clonus, (3.4%) for tone, (4.3%) for 
reflexes and lastly 3.7% affecting loss of sensation.  
 In our study the cerebral malaria with the above-mentioned clinical 
signs was associated with poor outcome and death. These results were 
consistent with the finding of another study in that, cerebral malaria is the 
most common cause of death among patients with severe malaria(60). 
Convulsions, presence of unconsciousness and its duration were the only 
three independent risk factors and were the predictors of squelae(66). All 
children with severe malaria, and specifically with cerebral malaria should 
be examined and assessed thoroughly, so as to guard against morbidity and 
mortality.   
4.7.7. Musculo-skeletal system: 
Generalized body ache was noted in (21%) of the patients, arthralgia 
was noted in (19.0%), backache noted in (10.3%), abnormal gait was noted in 
(1.24%) and neck rigidity was noted in (0.53%) patients. 
4.8. Investigations performed:  
4.8.1. Routine investigations:  
• Urine analysis:  
Urine was acidic in all specimens. Tea coloured urine was detected 
in (2.5%) of the patients. Haemoglobinuria was detected in (50.4%) of the 
patients. This is not consistant with Tchokoteu, et al study who found 
haemoglobinuria in (1.3%) of the patients and Banzal et al study who 
detected haemoglobinuria in (15.4%) of the patients(225, 42).   
 The WHO report in (2000) stated that malarial haemoglobinuria is 
uncommon and is usually associated with hyperparasitaemia(46).   
Anuria was noted in (5.3%) of the patients. This percentage was 
more or less corresponding to the percentage (8.0%) of children who were 
found  to have moderate to severe dehydration, and this anuria may be due to 
the state of dehydration. More marked anuria was found in children who 
required dialysis due to malarial renal failure(229).   
4.8.2. Haematological tests: 
Anaemia is an inevitable consequence of severe malaria. 
Haemoglobin less than 5g/dl was detected in (61.8%) of the patients in our 
study which is much higher than that found by other studies(236,225,237). 
Malaria is an important cause of anemia in the tropics, as evidenced by 
many studies carried out on African children which showed a sudden and 
profound fall of the haemoglobin concentration after acute malarial 
attack(39,53). In addition to haemolysis a defective bone marrow response 
appeared to play a role in the pathogenesis of anemia(31). WHO (2000) stated 
that severe anaemia is often multifactorial, and is attributable to malaria 
because of parasitaemia and the lack of an adequate alternative 
pathogenesis(35). Most of the main age groups detected had low 
haemoglobin. In this study there was strongly statistical relation between the 
age and haemoglobin concentration.  
Group O +ve was the most prevailing blood group (35.0%) of our 
studied patients, followed by group A+ve (33.9%). A study in Zimbabwe 
found that patients with malaria and group A blood had lower haemoglobin 
levels and more risk of coma than did infected patients with other blood 
group(238). Leucocytosis was detected in (5.2%) of the patients and 
leucopenia in (53.8%) of the patients. Leucopenia is common in some 
population(60). Thrombocytopenia (less than 150,000/cc) was noted in 
(16.2%) of the patients. This finding is not consistant with Banzal study who 
found thrombocytopenia in (50.4%) of the patients(42).   
4.8.3. Tests for malaria parasites: 
Plasmodium falciparum was noted in (89.5%) of the patients, 
Plasmodium vivax in (9.8%), whereas, mixed infection was only in (0.7%) 
of the patients. These findings disagree with Daoud and Angyo et al studies 
who detected plasmodium falciparum only in their studies(123,227).   
4.8.4. Biochemical tests: 
Hypoglycemia is a recognized complication of falciparum malaria, in 
this study (22.3%) of the patients were hypoglycaemic, which is almost 
double (11.6%) that reported by Assimadi et al study, which was associated 
with poor prognosis and higher than others studies(86,85,51). Hypoglycemia in 
this study was significantly affected by the age group, (23.9%) of the 
patients were (< 4 years) compared with other age groups(P<0.05). Blood 
urea and creatinine were high in (69.3%) of the patients, compared to a 
minority of only (6.1%) in another study(42).  
Serum sodium was the most commonly affected of the serum 
electrolytes. Abnormal serum sodium level (hypo/hypernatremia) was 
detected among (76.4%) of the studied children compared with (12.8%) and 
(13.0%) for serum potassium and serum chlorides respectively. All patients 
showed abnormal serum bilirubin and the majority of them (89.7%) showed 
elevated direct serum bilirubin. Nearly all of the patients showed elevated 
(ALT), whereas, (AST) was elevated among only (53.8%) of the patients. 
This was similar to the findings in other studies. Banzal et al recorded 
elevated (ALT) in (6.9%) of their patients(42).  
Blood gases analysis in our study showed abnormal bicarbonate level 
among all the patients, followed by (84.7%) for base excess, (PO2) was 
abnormal in (20.4%) of the patients and oxygen saturation was abnormal in 
(16.0%) of the patients. Usen et al in Gabon reported oxygen saturation 
<90.0% in (5.9%) and that hypoxaemic children were five times more likely 
to die than non hypoxemic children(239).   
 
 
 
 
 
4.8.5. Special tests: 
4.8.5.1. Haptoglobin phenotype:  
In this study haptoglobin phenotype (1-1) was detected in (48.1%) of 
the patients, haptoglobin phenotype (2-1) was detected in (21.7%) of the 
patients, while haptoglobin phenotype (2-2) was detected in (17.6%) of the 
patients. This finding was consistant with other studies(89,92). The finding 
also suggested that haptoglobin phenotype (1-1) was associated with 
susceptibility to falciparum malaria and the development of severe 
disease(89,92). Alternatively, Elagib et al concluded that the other phenotypes 
(2-1) and (2-2) may confer resistance. On the other hand Aucan et al in 
Gambia studied the haptoglobin phenotype in 1183 patients with severe 
malaria and concluded that there was no significant association between 
severe malaria and either haptoglobin genotypes or phenotypes(93).   
Hypo or ahaptoglobinemia was detected in (12.6%) of the studied 
patients, which was due to severe malaria causing haemolysis. Hypo or 
ahaptoglobinaemia is mainly due to malaria induced haemolysis(97). 
Repeated malaria attacks cause ahaptoglobinaemia(99). Low serum 
concentration of haptoglobin was found in semi-immune and non-immune 
patients(98). In Mizushima et al study in Solomon Islands concluded that 
malaria may not be the major cause of ahaptoglobinaemia(96).  
4.8.5.2. Parasitaemia:  
Parasitemia level < 5% was noted in (62.9%) of the patients, 
whereas, parasitaemia > 10% was noted in (7.3%) of the patients. The 
degree of parasitaemia (parasite density) did not differ statistically among 
the different age group. No statistical significance difference between 
socioeconomic classes and parasitaemia was found in our study. This was 
consistant with Luckner et al study in which socioeconomic factors are not 
major determinants of hyperparasitaemia in children(52).   
In our study there was a strong negative correlation between the level 
of parasitaemia and both haemoglobin level and platelets counts. This 
finding was similar to Kakkilay's et al study in which the degree of anaemia 
correlate with parasitaemia(37). However, this was different from the findings 
of Das et al study in which parasitaemia did not significantly correlate with 
haemoglobin concentration(34). There was a strong positive correlation 
between parasitaemia and both total and direct bilirubin levels.   
4.9. Treatment: 
4.9.1. Supportive and symptomatic treatment:  
Regarding supportive and symptomatic treatment, almost all the 
children of the study (99.8%) received treatment in the form of antipyretics 
and intravenous fluids.  
4.9.2. Specific treatment: 
Specific treatment included intravenous quinine and oral quinine for 
(97.9%) and (94.5%) of children respectively. Antibiotics were received by 
(58.6%) of children. The least drugs to be used were anti-convulsants which 
were given to only  (9.1%) of the children. 
4.10. Complications and outcome: 
This study had detected complications of malaria infection among 
children in the following order: renal affection (69.3%), hypoglycemia 
(22.3%), thrombocytopenia (16.2%), cerebral malaria (9.1%). The mortality 
rate among children of the study group was (1.6%). The causes of death 
were cerebral malaria, associated with hypoglycemia and respiratory distress 
with cardiopulmonary arrest in most of the patients(77.8%). Acute renal 
failure was the cause of death in only two patients (22.2%).  
Our findings concerning cerebral malaria rate and death rate differed 
greatly from the findings of other investigators. Waller et al. (1995) in 
Gabon found cerebral malaria among (43.0%) and death rate of (15.0%) of 
the affected children(51). Angyo et al. (1996) in Nigeria found that cerebral 
malaria and death rate among (17.6%) and (3.2%) respectively with cerebral 
malaria responsible for (56.3%) of deaths(227). In Kenya, Marsh et al. (1995) 
found that the mortality rate was (3.5%)(53), whereas, Assimadi et al. (1998) 
in Togo found much higher death rate (18.9%) of their patients(86). Cerebral 
malaria was found among (26.0%) of the studied children in Cameron(225). 
On the other hand, Greenwood et al. (1991) reported cerebral malaria rate of 
(2.0%) only(1). In our study we noticed no difference regarding cerebral 
malaria rate in relation to age. Imbert et al. (1997) in Senegal found that 
cerebral malaria rate increases with increased age, it was (11.3%), (28.2%) 
and (60.6%) among age groups 0-3, 4-7 and 8-15 respectively(38). 
4.11. Comparative clinical features of malaria in children: 
4.11.1. Simple and cerebral malaria: 
The mean duration of fever before coming to hospital was shorter 
among children with cerebral malaria compared with children with non-
cerebral malaria. All children with cerebral malaria came to the hospital 
within the first week of onset of fever, which significantly differed from the 
group with non-cerebral malaria. There was no statistical significant 
differences between children with cerebral and children with non cerebral 
malaria as regards occurrence of fever and its grade. Headache was more 
frequent among children with cerebral malaria. Neck rigidity was the only 
musculo-skeletal complaint that showed significant difference between 
children with cerebral and children with non-cerebral malaria, it was more 
among the first group. These are signs of meningeal irritation and cerebral 
affection which is the mainstay of the cerebral malaria. Anorexia was the 
only gastrointestinal complaint that showed significant difference between 
children with cerebral malaria and children with non-cerebral malaria. It was 
higher among the first group. Anorexia is the symptom of severe stress 
which is common in cerebral malaria. 
This study showed no statistical significant differences between 
children with cerebral and children with non-cerebral malaria, concerning 
vaccination coverage, past history of malaria and past history of cerebral 
malaria, which is expected because no other studies showed such 
correlation. Poor housing condition forms the majority of houses of children, 
however, it was significantly higher among children with cerebral malaria 
which forms a good environment for the vectors and children are more 
exposed to mosquito bites. 
 Pallor and undernutrition were significantly higher among children 
with non-cerebral malaria. However, the degrees of undernutrition did not 
show such a difference between the two groups. Although dehydration did 
not differ between both groups, severe dehydration was significantly higher 
among children with cerebral malaria. 
Unexplained finding in this study was that, the mean hamoglobin 
concentration among children with cerebral malaria was found to be higher 
than those with non-cerebral malaria with statistical significance differences. 
This was consistant with other study which suggested that severe malarial 
anemia and cerebral malaria are influenced by separate genetic factors 
situated near the TNF gene (106). 
 The mean respiratory rate and the mean pulse rate were significantly 
higher among children with cerebral malaria compared with children with 
non-cerebral malaria. This is explained by the coexistent pneumonia, direct 
sequestration of the malaria parasite in the lungs, or increased central 
deprivation to respiration in association with cerebral malaria which is 
consistent with Marsh et al in their studies (29).    
There was statistically significance differences between children 
with cerebral and children with non cerebral malaria according to their limbs 
abnormalities. All parameters were higher in cerebral malaria children than 
non cerebral malaria children except coordination (higher in non-cerebral 
malaria). Nystagmus, pupil abnormalities, absence of light and corneal 
reflexes were significantly more prevalent among children with cerebral 
malaria. This is because of the cerebral insult occurring in cerebral malaria. 
No statistical significant differences were detected between children with 
cerebral and children with non-cerebral malarial infection as regard 
hepatomegaly and splenomegaly. However, splenomegaly was higher 
among children with cerebral malaria and no other studies showed 
differences between cerebral and non-cerebral malaria as regard of 
hepatosplenomegaly.  
Children with blood group O-ve were the most commonly affected 
by cerebral malaria followed by blood group A-ve (37.5%) and (28.6%) 
respectively. This was not consistent with another study in which blood 
group O was associated with resistance to malaria (238).  
As regard haptoglobin phenotype, there was no statistical 
significance between children with cerebral and children with non-cerebral 
malaria. This was not consistant with findings in other studies(89,92). On the 
other hand, the study revealed no difference between children with cerebral 
and children with non-cerebral malaria concerning hypoglycemia. This was 
inconsistent with White et al studies in which hypoglycaemia was frequently 
found in children with cerebral malaria(83). 
The mean serum sodium level was significantly higher among 
children with non-cerebral malaria, whereas, the reverse was true concerning 
mean serum potassium level. On the other hand, the mean blood glucose 
level and mean serum chloride level did not show such differences. This can 
be explained by the association of (SIADH) with cerebral malaria which 
leads to dilutional hyponatraemia.   
PCO2 was significantly lower in children with cerebral malaria 
compared with children with non-cerebral malaria. Other blood gases 
parameters did not show such differences. This can be explained by rapid 
respiratory rate in cerebral malaria which leads to washout of Co2. 
4.11.2. Simple malaria in children and the control group: 
The mean blood glucose level did not show significant difference 
between both groups.  This agrees with what was reported by Kawo et al., 
(1990), who found that the frequency of hypoglycemia did not differ 
significantly between malarial and control patients and that hypoglycemia is 
not a specific complication of malaria(85). 
All parameters of liver function tests, renal function tests and lipid 
profile (except cholesterol level) were found significantly higher among 
children infected with malaria. Baptista et al. (1996), compared 2 groups of 
the patients, children infected with Plasmodium falciparum (simple malaria 
and cerebral malaria) with a control group. They found no correlation 
between lipid plasma level and disease severity(240). While comparing 
children with malaria patients and control group we found statistically 
significant changes (P = 0.001) between both groups. Haptoglobin 
phenotype percentage among the control group were (1-1) among (9.0%), 
whereas (36%) and (15%) for haptoglobin (2-1, 2-2) respectively. However, 
haptoglobin phenotype percentages in malaria patients were (48.13%) for 
haptoglobin (1-1) and (21.86%) and (17.58%) for haptogobin (2-1, 2-2) 
respectively. Ahaptoglobinaemia percentage among control group was 
(39.0%) compared with malaria patients which was only  (12.6%).  
The findings of our study match with Elagib et al, and Quaye et al 
studies who found significant differences between malaria patients and the 
controls(89,92). However, the findings of this study was not consistant with 
Quaye who found no significance difference between both groups as regard 
Ahaptoglobinaemia(92).    
The magnitude of the problem 
The study was conducted to look into different aspects of malaria, 
the clinical pattern, the risk factors for mortality and the outcome.  
Malaria remains one of the most widespread potentially fatal 
infectious diseases. According to the WHO, malaria is endemic in 91 
countries, with about (40%) of the world's population at risk. People who 
live in endemic areas and have frequent infections acquired some immunity, 
so that they tolerate plasmodium falciparum parasitaemia with mild or no 
symptoms. However, in non-immune people, falciparum infection always 
causes debilitating illness and must be regarded as potentially fatal disease. 
Malaria is a major health problem in Yemen. Malarial in Yemen is 
edidemiologically classified as "Afrotropical" which is the worst 
epidemiological malaria situation worldwide. The estimated annual malaria 
cases in Yemen is 1,500,000 to 1,800,000 with fatality rate of (1%) 
especially among those below 5 years of who are more prone to severe and 
complicated malaria.  
Malaria is a disease which can be control by simple measures, such 
as spraying insecticides, personal protection and wide spread use of nets. 
Draining stagnant water is especially important measure, because of its 
widespread in the rural community   
 
 
 
 
 
 
 
 
 
CONCLUSION AND RECOMMENDATIONS 
  
CONCLUSION: 
• Malaria remains the most prevalent and public health problem in Yemen 
despite considerable efforts of the government, Ministry of Health, WHO 
collaboration, health education and community participation. Control of 
malaria remains a difficult problem.  
• The commonest clinical presentation is severe anaemia found in (86.6%), 
under-nutrition found in (80.2%), renal affection found in (69.3%), 
hypoglycemia in (22.3%), thrombocytopenia in (16.2%) and cerebral 
malaria in (9.1%) of studied children. Other presentations such as fever 
(universal), GIT (vomiting 66.6%), chest (cough 48.1%) and were found 
to be associated with severe malaria. Haptoglobin 2-1 was the 
commonest type among normal control group (37.0%).  
• Plasmodium falciparum is the commonest species (89.5%), followed by 
P. vivax (9.8%), and mixed in (0.7%).  
• The endemicity according to parasite load showed that (62.9%) of 
studied cases with parasitemia < 5% and (29.8%) with parasitemia 
between 5% - 10%. From the parasitaemia level Hajjah is considered 
hypoendemic.  
• Regarding children with blood group O +ve malaria was found in (35%) 
followed by A+ (33.9%). Blood group O -ve (37.5%) was the most 
commonly complicated by cerebral malaria followed by A -ve (28.6%). 
However, blood group O -ve was the group showing statistical 
significant difference between children with cerebral and non-cerebral 
malaria (P = 0.005).     
•  The presence of respiratory distress or impaired level of consciousness, 
absent corneal reflexes or retinal haemorrhage is serious and can identify 
those at risk for death.  
• Anaemia and hypovolaemia are risky factors by themselves or as 
contributing factors for metabolic acidosis and its clinical respiratory 
distress.  
• Quinine 10 mg/kg 8 hourly for 7-10 days is the treatment of choice for 
severe and complicated malaria.  
 
 
 
 
 
 
 RECOMMENDATIONS: 
• A definite diagnosis of severe malaria should be made early and such 
diagnosis.  
• Severe malaria should be managed promptly to avoid unnecessary 
mortality and morbidity.  
• Because no antimalarial drugs can guarantee absolute protection against 
infection, basic preventive measures like the use of mosquito 
impregnated bed-nets, insecticides ,mosquito repellants and elimination 
of the mosquito breeding areas are advocated for those at risk of malaria.  
• Massive alertness and rapid treatment through primary health care and 
rapid detection of complications, with especial emphasis on children 
below five yeas of age and those who had risk factors such as anaemia, 
hypoglycaemia, leucocytosis, deep coma, absent corneal reflexes and 
retinal haemorrhage.  
• More health centers, more educational facilities to make the people 
especially those in the rural areas aware about preventive measures. 
• Since the respiratory findings are more common in children with malaria, 
so malaria should be considered in any child with symtomps related to 
this system. 
• A special unit for malaria in the main hospital is advisable with subunits 
in the surrounding health centres. 
• More research in this field should be encouraged especially chloroquine 
resistance, why control is not working as well as should. 
• As malaria is so endemic and the mean weight of children is low, it may 
advisable to give chloroquine and folic acid to pregnant women.   
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
